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ABSTRACT 
Maintenance of epithelial tissue integrity requires correct organization of 
the polarity plane. This is promoted by assembly of cell-cell junctions, defining 
distinctive apical and basolateral domains. The establishment of polarity is a key 
point in tissue organization since it controls the plane in which cells divide. When 
a cell replicates, it duplicates DNA and aligns them before partitioning them 
evenly between the two daughter cells. Although results from different 
laboratories indicate a role of cell-cell junctions in the orientation of the mitotic 
spindle, it is poorly understood if there is a cross-talk between the mitotic 
checkpoint and the attachment status of the microtubules at the cell cortex.  
Previous works suggest that the small Rho GTPase Cdc42 regulates spindle 
orientation and chromosome capture. Cdc42 is also a crucial regulator of cell-cell 
junction assembly and dynamics. Cell junctions need to remodel during cell 
division to adapt to the changing cell shape, and allow the condensed 
chromosomes to be properly aligned. Therefore, we hypothesized that specific 
regulators of Cdc42 guide the interplay between cell junctions and the mitotic 
machinery.  
Using a siRNA approach, we identified a GAP for Cdc42, DLC2, that 
associates with cell-cell contacts and mitotic spindles, and regulates junctional 
integrity and chromosome attachment during mitosis. Upon depletion of DLC2 in 
epithelial cells, the normally continuous immunofluorescence staining of 
junctional markers was disrupted in mitotic cells, and chromosomes are 
misaligned.  
Following DLC2 depleted cells on live, it results clear that these cells are 
arrested in metaphase for longer timing, with some chromosomes unattached. The 
orientation of mitotic spindles relative to the substrate was not affected, 
suggesting that the defect was not due to a loss of polarity. Depletion of DLC2 led 
to increased levels of GTP-bound Cdc42, indicating that deregulation of Cdc42 
contributed to the observed phenotypes. Indeed, partial depletion of Cdc42 by 
RNA interference rescued the phenotype induced by depletion of DLC2. We also 
found that DLC2 associates with the plus-end motor Kif1B, a kinesin-3 family 
member, and that depletion of Kif1B resulted in a similar phenotype as depletion 
of DLC2. Based on our observations, we speculate that DLC2 regulates Cdc42 to 
guide association of microtubules with the cell cortex and the kinetochores in 
metaphase and to regulate forces they exert at these sites. 
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CHAPTER 1: INTRODUCTION 
1.1 Maintaining epithelial integrity has its rules 
Epithelia are tissues that cover external surfaces of the human body and 
line inner cavities of organs. Although each epithelium is peculiar and has a 
specific function, among the common main roles epithelia act to protect the 
organism against pathogens and injuries, and to select carefully what crosses the 
epithelium and enters in the body (nutrients, ions, salts and water).  
Despite the fact that the structure of an epithelium can be more or less 
complex (“simple epithelium” with only one layer of cells or “stratified 
epithelium” formed by two or more cellular layers), all of them are composed by 
specialized cells tidily and compactly arranged in the tissue. The correct 
organization of these cells is crucial for maintaining the integrity of the barrier1. 
Damaging the epithelial integrity can be dangerous in several ways. It 
might favour exposure to pathogens and microorganisms, which can freely invade 
the organism and injure other tissues (Figure 1.1). Nevertheless, the danger does 
not only have to come from outside, but it might hide behind an uncontrolled 
homeostasis of the epithelial tissue itself. Many epithelial tissues can regenerate by 
proliferation and replacing the damaged cells. This is an advantage on one hand 
because it ensures that the integrity of the barrier will be restored after an injury, 
but, on the other hand, it represents a factor of risk. Indeed, if the proliferative 
potential of an epithelium is not wisely controlled, it can trigger cancer formation. 
Nowadays, it has been estimated that about 90% of all human cancers have an 
epithelial origin2. 
Hence, proper regulation of tissue homeostasis is of paramount importance. 
The correct organization of an epithelium is dependent on three features: first, the 
capability of these cells of establishing intercellular adhesion structures; second, 
the formation of apical and basal surfaces that align with the tissue barrier; third, 
proper controlled and specifically orientated cell division3. 
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Figure 1.1 The epithelial barrier  
A schematic representation of a simple columnar epithelial layer. These tissues are exposed 
continuously to the external environment. Hence, pathogens and other types of dangers such as 
mechanic stress or wounds (red arrows) can compromise its integrity.  To maintain the barrier 
integrity, epithelial cells exhibit specific and peculiar physical and biochemical features, such as the 
complex of epithelial junctions (little green bridge across two neighbouring cells). This complex is 
located in the apical position and defines the border between apical and basal domain (yellow 
boxes). The correct functionality of junctions is required for the paracellular transportation (blue 
arrows through the junctions) of waters and selected nutrients molecules and ions. Moreover, the 
epithelial barrier is able to regenerate, by duplicating within the layer, to replace damaged cells 
(green arrows).  
 
 
1.2 The “epithelial junctional complex” 
Epithelial cells assemble specific structures to bridge the space between 
neighbouring cells that are known as junctions. Junctions allow cells on one hand 
to adhere to each other and on the other hand to regulate the flux of molecules 
through the space between cells (paracellular transport). In mammals, adhesion is 
generally mediated by three types of junctions: Tight Junctions (TJs), Adherens 
Junctions (AJs) and Desmosomes. The complex of these three is also referred as 
the “epithelial junctional complex”4 (Figure 1.2). 
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Figure 1.2 The Epithelial junctional complex  
Components of the vertebrate epithelial junctional complexes found in polarized epithelia cells. This 
complex is formed by TJ, tight junction; AJ, adherens junction; Des, desmosome. Components of 
each type of junctions are listed in the yellow table on the right.  
 
 
1.2.1 Tight Junctions 
Tight Junctions are the most apical component of the epithelial junctional 
complex. They were visualized for the first time in utlrathin section by electron 
microscopy and appear to be contacts site, bringing opposite membranes next to 
each other, like gates for the regulations of molecules in the space between the 
cells5,6.  
Epithelial TJs group several transmembrane proteins: the tetraspans 
occludin, claudins, tricellulin, MarvelD3, the single transmembrane proteins JAMs 
(junctional adhesion molecules) and Crb-3, and Bves with three transmembrane 
domains. These proteins are involved in the adhesive contacts and regulate 
paracellular permeability. The role of the junctional membrane proteins in 
paracellular permeability is supported by the observations that overexpression of 
C-terminally truncated occludin causes paracellular leakage of small tracers in 
MDCK cells7 and knock-out of some claudin genes in mice results in permeability 
defects, such as deletion of the claudin-1 gene, which led to death after birth 
because of water loss across the skin8.    
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Many of the transmembrane proteins contain PDZ-binding domains. This is 
thought to be important for the recruitment of proteins containing the PDZ 
(PSD95/DlgA/ZO-1 homology) motif, which has been found in many proteins 
forming the junctional “plaque”, such as ZO-1, ZO-2 and ZO-3 (Zonula Occludens 
1-2-3), PAR3 (partitioning defective 3) and PAR6 (partioning defective 6), Pals1 
(protein associated with lin seven 1) and PATJ (PALS1-associated tight junction 
protein), the MAGIs (membrane-associated guanylate kinase inverted) and 
MUPP1 (multi-PDZ domain protein 1). 
Proteins of the plaque are involved in many signalling cascades: some can 
connect the TJs to the actin fibre network (such as ZO-1, ZO-2, ZO-3), some work 
as transcription factors (e.g. ZONAB), and others regulate assembly and 
permeability of TJs (PAR3 and PAR6, Pals1 and PATJ)9. These classes are not 
exclusive though, and most of these proteins play a role in more than one 
pathway. ZO-2, for instance, has been seen to localize in the nucleus, where it 
participates in the regulation of transcription of genes10. Regulation of ZONAB 
nuclear localization is controlled by cell density. In proliferating cells, ZO-1 is 
expressed at low levels, whereas ZONAB at high levels. ZONAB forms a complex 
with the cell division kinase CDK4. During proliferation, the ZONAB/CDK4 
complex dissociates from ZO-1 and goes to the nucleus whereas ZO-1 stays in the 
cytoplasm. This defines a role for ZONAB in the regulation of entry into S-phase11. 
On the contrary, in high-density cells, ZO-1 is expressed at high and ZONAB at 
low levels, with consequent cytoplasmic sequestration of ZONAB as well as the 
interacting cell-cycle regulator CDK4.  
It has been reported that the expression of several TJ components is affected 
in various carcinomas, although, it is not entirely understood how alteration of 
tight junction components leads to carcinogenesis. Claudins expression is 
particularly confusing as, depending on the type of tumour and the type of 
claudin, expression can be upregulated or reduced. For example, despite Claudins 
expression varies from tissues to tissue, Claudin-1 depletion had been shown to 
inhibit cell migration and metastatic behaviour in colon cancer, which may reflect 
a role of claudins in cell-matrix adeshion12. Similarly, OSP/claudin-11 and and β1 
integrin complex downregulation inhibits proliferation and migration of 
oligodendrocytes, a process essential for normal myelination and tissue repair13. 
ZO-1 expression is decreased in breast cancer, which is considered to be a marker 
of poor prognosis14. By contrast, ZONAB is upregulated in hepatocellular 
carcinoma15. 
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1.2.2 Adherens Junctions 
Adherens junctions initiate and stabilise the cell-cell contacts. 
Intracellularly, they bind and regulate the actin cytoskeleton and the microtubule 
network, originate signalling cascades and direct transcriptional regulation, 
similarly to tight junctions. Adherens junctions are composed of transmembrane 
members of the cadherin superfamily and of intercellular adhesion proteins 
belonging to the catenin family. The transmembrane glycoprotein E-cadherin 
interacts with the cadherins on neighbouring cells. Interestingly, binding of Ca2+ to 
each E-cadherin molecule switches the weak initial interaction to strong adhesive 
sites: the presence of Ca2+ leads to the correct extracellular domain cadherin 
conformation and stabilisation of the interaction16,17.  
Cadherins can associate intracellularly with proteins of the catenin family. 
In particular, α−catenin can either act as a monomer or homodimer. It was shown 
that that monomer or a homodimer forms of α-catenin have different binding 
properties18. The homo-dimers of α-catenin bundle actin fibres and compete for 
Arp2/3 bining on the actin fibres, preventing the formation of branching networks 
of actin filaments19. On the contrary, the monomeric α-catenin binds more strongly 
to E-cadherin-β-catenin via the intracellular tail of E-cadherin. β-catenin binds also 
the C-terminal cytoplasmic domain of E-cadherin but in a phospho-regulated 
manner. It has been proposed that phosphorylation of Y142 on β-catenin favours 
BCL9-2, a transcription factor involved in epithelial-mesenchymal transition, and 
induces a relocalization of β-catenin in the nucleus where it acts as transcription 
factors20. 
Another member of the cytoplasmic core of the adherens junctions is 
p120catenin. This catenin is able to bind to the cytoplasmic tail of cadherins and it 
has been suggested that it increases the retention of cadherins at the plasma 
membrane. Loss of p120catenin destabilizes E-cadherin contacts and leads to 
tumour progression and invasion21. Moreover, p120catenin regulates microtubules 
dynamics via EB1 binding and by stabilizing the plus ends. p120catenin depletion 
results in an increase of catastrophe events and promotes cell migration22. 
Among the transmembrane proteins of AJs we also need to mention nectin 
proteins. There are four nectin family members (nectin 1-4), which are Ca2+-
independent immunoglobulin-like adhesion molecules23. In contrast to cadherins, 
nectins are able to trans-interact both homophilically and heterophilically 
(interactions between the same and different nectin members), and their 
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heterophilic trans-interactions are much stronger than their homophilic trans-
interactions. Alongside cell adhesion, nectins regulate various cellular functions, 
such as cell movement, proliferation, polarization, survival and differentiation.  
 
1.2.3 Desmosomes 
Desmosomes are intercellular junctions anchoring intermediate filaments at 
the cell cortex. They do play an adhesive role, and also participate in cell 
signalling during development, tissue morphogenesis and wound healing. 
Desmosomes are composed of the desmosomal cadherins desmoglein 
(DSG) and desmocollin (DSC), and desmosomal plaque proteins that include 
desmoplakin (DP), and the arm (armadillo) proteins plakoglobin (PG) and 
plakophilin (PKP). DP connects the desmosomal plaque to the intermediate 
filaments, and PG and PKP are adaptor proteins that link the desmosomal 
cadherins and DP24. 
Desmosomal adhesion molecules contain five repeats of a calcium binding 
domain. Upon calcium binding, a conformational change occurs and leads to a 
strongly adhesive state known as hyperadhesion. When hyperadhesion is 
established, this state becomes insensitive to calcium chelation25. Only under some 
conditions of wound repair and neoplasia can desmosomes switch back to a Ca2+-
dependent state26. 
The importance of desmosomes in normal tissue function has become more 
evident with the start of genetic loss-of-function studies. It was reported that 
constitutive deletion of Dsc3, Dsg2 or Dsp causes early embryonic lethality 
probably because of defective adhesion in processes related to implantation. In 
contrast, mice withconstitutive knockout of Dsc1 or Dsg3 or with conditional 
deletion of Dsp or Dsc3 in the skin survive, but they show epidermal integrity 
defects. Moreover several human diseases have desmosome components 
inactivated by mutation, or targeted by autoantibodies or proteolysed by bacterial 
toxins. Loss or reduction of any of DSG1-3, DSC2, DSC3, PG, PKP1-3 and DSP has 
been reported frequently in several human epithelial cancers (skin, head and neck, 
gastric, colorectal, bladder, breast, prostate, cervical and endometrial cancers)27.  
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1.3 Establishment of cell-cell contact sites 
Although the establishment of cell polarity can vary between model 
organisms and different mammalian epithelial cells, in a simple epithelium this is 
driven by the assembly of cell-cell contacts. Behind this complicated and not 
entirely understood mechanism lays a delicate equilibrium of interplay between 
TJs, AJs and cell polarity complexes. The cell polarity complexes are largely 
conserved among flies, worms, yeast and higher organisms. Three major polarity 
complexes have been identified: the PAR polarity complex, including PAR3, 
PAR6, atypical protein kinase C (aPKC) and cell division control protein 42 
(CDC42), responsible for the establishment of the apical-basal membrane border; 
the crumbs (CRB) complex, formed by CRB and PALS1 and PATJ, required to 
establish the apical membrane; and the scribble homologue (SCRIB)–lethal giant 
larvae homologue (LGL) complex, which defines the basolateral plasma domain28. 
At the initial stages of the process, epithelial cells adhere to the substrate 
via their intergin receptors, they extend filopodia to look for other cells around 
and contact them. Once they found each other, the nectin–afadin complex 
associates with PAR3, and is thought to trigger the recruitment of E-cadherin and 
JAM-A to the cell cortex (Figure 1.3). These primordial adhesion sites are known 
as puncta and are composed by a mixture of AJs and TJs components. Under the 
fine regulation of Rho-GTPase activity, the primordial junctions anchor the actin 
cytoskeleton and progressively extend the interface of adhesion along the 
basolateral domain29. The process involves both, the active GTP-bound Rac, which 
stimulates the activity of phosphatidylinositol 3-kinase (leading to the formation 
of PIP2), and the activation of Cdc42 with the following Arp2/3- mediated actin 
nucleation as well as the recruitment of cortactin, Mena, PAK-4, and formin-1. 
Several studies showed that cell–cell junction formation is modulated in a force-
dependent manner30. When E-cadherin-expressing cells contact each other, MLC 
phosphorylation increases, and myosin II is recruited to the peripheral zone of the 
contact where it aids in expanding the contact area and strengthening31–33. Next, 
adherens junctions are separated from tight junctions and the complex matures to 
the typical belt-like structures with distinct adherens and tight junctions. This 
happens when PAR3 is excluded from apical sites. Even at this stage active Cdc42 
and active Rac1 play an important role: via Par6, they lead to the activation of 
atypical PKC (aPKC). aPKC (PKCι and PKCζin humans) phosphorylates Par3, 
leading to its dissociation from PAR6/aPKC and exclusion from the apical 
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domain, allowing tight junction formation and separation of the apical and 
subapical domains29 (Figure 1.3).  
At the beginning of cell-cell contacts establishment, also RhoA activity 
plays an important role. In epithelial cells, the RhoGTPase family member RhoA is 
in fact activated at cell junctions on adhesion sites and, concomitantly, deactivated 
in other parts of the cells, contributing to reduced cell spreading and stress-fibre 
formation, and inhibition of proliferation. Regulation of RhoA at the cell-cell 
junctions is essential for the correct control of the junction-associated actinomyosin 
cytoskeleton, which drives apical constriction and tissue remodelling.  
Although the model of apical constriction involves constriction of actin 
filaments at the cell–cell AJs, recent work in the fly mesoderm and amnioserosa 
has revealed that constriction can also be triggered by an apical actomyosin 
network covering the surface of each cell34–38.  
 
 
 
Figure 1.3 Cell-cell contact maturation  
Formation of cell-cell contacts, establishment of the epithelial junctional comlex and determination 
of apical–basal polarity in mammalian epithelial cells. Initially, cells start contacting the 
neighbouring cells, by sensing them through filopodia and lamellipodia. At the contact site, E-
cadherins clusters together and recruit JAM-A (panel1). This triggers the activation of 
smallGTPases, in particular Cdc42 and Rac. Local activation of Par-3/Par-6/aPKC downstream 
Rac1 leads to maturation of junctions (panel2), with the separation of TJs and AJs components. 
While more proteins are recruited at cell junctions, RhoA regulates the zipper sealing. The process 
ends when the epithelial junctional complex is properly formed and the apical and the basal 
domains are spatially separated (panel3).  
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1.4 Small GTPases in the maintenance and regulations of Junctions 
I mentioned above that the assembly of cell-cell junctions is regulated by 
the activity of Rho GTPases. Rho GTPases are present in all eukaryotic cells, and 
they form a distinct family within the superfamily of Ras-related smallGTPases39,40. 
Whereas yeast Saccharomyces cerevisiae has 5 Rho proteins (Rho 1, 2, 3, and 4 and 
Cdc42), Caenorhabditis elegans and Drosophila melanogaster are predicted to 
have 10 and 11, respectively. In mammals, this subgroup comprises 22 genes. 
Among all the members of the mammalian gene family, the most studied and 
better characterised are the three Rho isoforms A, B, and C, the three Rac isoforms 
1, 2, and 3; and Cdc4241. 
As other Ras-like proteins, Rho smallGTPases act as molecular switches. 
They cycle between an inactive GDP-bound and an active GTP-bound form. The 
transition between the GDP- and the GTP-bound state is regulated by a variety of 
positive and negative regulators called GEFs, GAPs and GDI. GEFs are guanine 
nucleotide exchange factors and they facilitate the exchange of GDP for GTP42. On 
the contrary GAPs are GTPase activating proteins. They interact via specific 
residues of arginines (“arginine fingers”) directly with the Rho small GTPases and 
trigger hydrolysis of GTP to GDP43. GDIs are guanine nucleotide dissociation 
inhibitors (GDI), which, by binding the Rho GTPases in their GDP bound state, 
prevent the exchange of GDP with GTP and therefore the activation of the Rho 
GTPases (Figure 1.4). 
In their GTP bound state, Rho GTPases can bind effectors and signal to 
control pathways downstream. Over 50 effectors have been identified so far for 
Rho, Rac, and Cdc42 and they include serine/threonine kinases, tyrosine kinases, 
lipid kinases, lipases, oxidases, and scaffold proteins44. Via their own effectors, 
Rho GTPases are capable to trigger many more cellular responses, spanning from 
cell adhesion, migration, proliferation, cell survival, death and morphogenesis45.  
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Figure 1.4 Regulation of RhoGTPases  
RhoGTPases act as molecular switches and cycle between an active (GTP-bound) state and an 
inactive (GDP-bound) state. Binding to GTP induces conformational changes that allow 
RhoGTPases interaction with several effectors, which will pass the signal downstream. The 
temporal and spatial regulation of GTPase activity is tightly control by three classes of regulators: 
guanine nucleotide-exchange factors (GEFs), which promotes the exchanging of GDP with GTP; 
the GTPase-activating proteins (GAPs), that prompts the GTP hydrolysis activity of Rho GTPases, 
and will turn off the signal; the guanine nucleotide-dissociation inhibitors (GDIs), which block the 
release of GDP and trap the RhoGTPase in an inactive state.  
 
 
 28 
1.5 How do RhoGTPases control life of cell-cell junctions? 
One of the first evidences the role of smallGTPases in junction assembly 
dates to 1991: In that year, Balda et al showed how correct activation and 
deactivation of G proteins is required for junction formation. The authors took 
advantage of a technique known as calcium-switch. This is an experiment that 
involves culturing cells in a low calcium medium, in order to prevent assembly of 
cell-cell junctions. To follow up the junction assembly, it is possible to switch to a 
calcium-rich medium, which will trigger initiation of cell-cell contacts. In this 
experiment, Balda et al demonstrated that treatment with a non-hydrolysable GTP 
analogue, GTPγS, which prevents the correct cycling of GTPases, inhibits junction 
formation46. 
Moreover, treatment with C3 transferase (toxin capable to inactivate RhoA-
C, but not Rac or Cdc42) also results in inhibition of junction formation and affects 
junction permeability. Overall, these studies suggest that the fine balance of Rho 
GTPases activity is required for junction integrity. 
Years later, it became evident that regulations of Rho GTPases is 
orchestrated in time and space by specific proteins (GEFs, GAPs and GDIs). In 
fact, some of these regulators associated with junctions were reported to be 
fundamental for the correct establishment or maintenance of the apical junctional 
complex. Three TJ-associated GEFs have been identified and functionally linked to 
TJs: Tuba, GEF-H1 and p114RhoGEF. Tuba, a Cdc42 activator is recruited to TJs in 
a ZO-1- dependent manner and regulates junction assembly in a Ca2+-switch 
experiment47. GEF-H1 is a Rho GEF and it was shown to regulate paracellular 
permeability, as well as disassembly of junctions in response to calcium removal48. 
GEF-H1 is regulated by interactions with cingulin and JACOP/paracingulin, two 
homologous junctional adaptors. This interaction, by regulating GEF-H1 
recruitment to the junction, inhibits its exchange factor activity and is though to 
regulate RhoA-stimulated cell cycle progression49,50. Moreover, GEF-H1 directly 
binds to microtubules and in this state it is unable to activate RhoA51,52. Expression 
of mutated GEF-H1 unable to bind microtubules results in morphological changes 
associated with RhoA activation such as increased contractility and stress fiber 
formation.  
In contrast, p114RhoGEF is recruited to tight junctions by cingulin and 
activates RhoA restrictively at cell-cell junctions, leading ROCKII myosin II 
activation. Hence, depletion of p114RhoGEF inhibits junctions formation53. 
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One GAP was identified as regulator of junction assembly: SH3BP1, a 
GTPase-activating protein for Cdc42 and Rac. SH3BP1, via interaction with 
JACOP/paracingulin, a junctional adaptor, and CD2AP, an anti-capping protein, 
regulates spatial activation of Cdc42, controlling filopodia and junction 
formation54. 
At AJ, the RhoGEF Trio is know to associate with different cadherins, and 
regulate Rac1 activity via interaction with Tara (Trio-associated repeat on actin). 
Inhibition of Tara expression results in an enhanced Trio-mediated Rac1 activity, 
which leads to enhanced p38 activity and decreased E-cadherin expression. 
Alternatively, pharmacological inhibition of either Trio or p38 activity abrogated 
E-cadherin repression, suggesting that Tara controls a Trio-induced Rac1 and p38 
activation, controlling E-cadherin expression and adherens junction stability55,56. 
Tuba plays a role also on AJs. In fact, depletion of Tuba in Caco2 colon 
carcinoma cells causes fragmentation of E-cadherin and reduces actin filaments at 
the contact sites47. As downstream effectors of Cdc42, Wallace et al identified that 
Par6B and PAK4: the authors showed that with the establishments of contacts site, 
PAK4 and aPKC are recruited and they are essential for promotion of junction 
maturation57. 
Ect2 and p190 regulates RhoA activity to maintain junctional integrity in 
the latest stages of mitosis. In particular, centralspindlin, a cytokinetic regulator, 
localizes to the interphase zonula adherens by interacting with α-catenin. 
Centralspindlin recruits the RhoGEF, ECT2, to activate Rho. Centralspindlin also 
inhibits the junctional localization of p190B RhoGAP, and prevents inactivation 
Rho. 
A Rac1 GTPase-specific GTP exchange factor, Tiam1 (T lymphoma invasion 
and metastasis) has been shown to regulate junction stability. Its deregulation 
promotes breast cancer metastasis. Its activity is controlled by Par3. Loss of Par3 
results in higher Tiam1 activity and hence GTP-bound Rac level within the cell. 
This results in junction destabilization and invasive cell behaviour.  Expression of 
dominant-negative Rac or downregulation of Tiam1 rescued the Par3 loss 
phenotype. 
 
1.6 When the regulation of cell polarity is lost, cancer can evolve 
Maintaining cell polarity is crucial for tissue integrity and homeostasis. I 
refer here to previous sections where I presented how several cases of loss in cell 
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polarity proteins correlates to tissue disorganization and initiation and cancer 
progression. On the other hand, more than a decade ago already, it was shown 
that overexpression of wild-type and constitute-active forms of Rho GTPases in 
murine fibroblasts induces tumorigenesis58. Abnormal activity of RhoGTPases was 
also reported to be able to enhance metastases59,60 (Figure 1.5). 
Considering the role that RhoGTPases play in the modulation of cell-cell 
junctions, it is not surprising that one of the models proposed for RhoGTPases to 
trigger cancer formation is via deregulation of cell polarity. 
Interestingly, although for the three Ras isoforms, Ki-Ras, N-Ras and Ha-
Ras, mutations were found in 15% of all human tumours, RhoGTPases are only 
rarely mutated in tumours. Instead, their activity is often misregulated in cancer.  
RhoA is proposed to stimulate actomyosin-based cortical contractility via 
ROCKs and lead to disorganization of cell polarity and acquisiton of a more 
migratory phenotype. Abnormal activation of RhoA in cancer has been reported to 
be associated with the oncogenes Dbl, Ost, Ect-2, GEF-H1 and Vav-1, all 
RhoGEFs61. On the contrary, RhoGDI or RhoGAPs are usually decreased in 
expression or lost in the case of tumorigenesis. One famous case of RhoGAPs 
reported as tumour suppressors is the family of DLCs proteins, which were first 
found to be deleted in liver cancers and afterwards were found to be 
downregulated in many other cancers such as breast, colon and prostate 
carcinomas62. 
Similarly, Cdc42 expression is upregulated in some breast cancers63, and 
liver-specific knock-out indicates that loss of Cdc42 enhances liver cancer 
development64. Cdc42 activity was shown to be modulated by the Par polarity 
complex Par3, Par6 and aPKC. Overexpression of Par6B was reported in breast 
cancer and results in loss of TJ assembly and membrane localization of atypical 
PKCζ (aPKC). Interestingly, Cdc42 depletion also resulted in broken TJs, 
confirming that for a stable TJ complex a complete PAR6-aPKC-CDC42 is 
required65.  
Moreover, multiple studies suggest that aPKC is involved in the 
progression of human cancer, and in human non-small cell lung cancer (NSCLC), 
aPKCz overexpression correlates with poor prognosis66. On the contrary, Par3 is 
lost in many varieties of cancer, such as pancreatic cancers, breast cancer 
melanomas, colorectal carcinomas, head and neck squamous cell carcinomas, 
leukaemias, hepatocellular carcinomas, ovarian cancers, neuroblastomas, prostate 
cancer, bladder cancer67. 
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Regarding Rac, little is known about its role in cancer progression in vivo. It 
has been shown that Rac1 knock-out in mice is embryonic lethal68, therefore, 
conditional knock-out mice have been studied extensively. Deletion of Rac 1 in 
lung seems to be required for K-Ras-induced tumorigenesis to take place69. 
Interestingly, mice lacking Tiam1, a Rac-specific GEF, are less susceptible to Ras-
induced skin cancer and develop fewer tumors, although when tumors form they 
are more aggressive70.  
Moreover, destabilization of junctions is fundamental for triggering cell 
migration. Misregulation of junction stability is indeed linked to invasive 
behaviour and metastasis progression. It is important to underline here that, 
although I did not go in details in how smallGTPases and their regulators are 
involved in cell migration, many of the proteins I discussed above and in the 
previous sections can also promote cancer metastasization.  
 
 
 
Figure 1.5 Table of some smallGTPases and their effectors/regulators altered in cancer 
The table reports names of proteins (yellow box), evidences of their involvement in cancer tissues 
(orange box) and specific references (grey box).  
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1.7 Maintaining cell polarity in a dividing cell 
Due to the position of most epithelia in the body and their role as a 
protective barrier, it is evident that epithelial tissues are constantly exposed to 
damages and injuries. In fact, they need often to replace damaged or dead cells to 
maintain the integrity of the tissue71 or do so as part of the normal self-renewal of 
a tissue. The continuous cell replacement is called tissue homeostasis and it varies 
among different epithelia. The intestinal epithelium completely self-renews within 
5 days, the interfollicular epidermis takes 4 weeks to renew; the lung epithelium 
can take as long as 6 months to be replaced.  Some epithelia undergo renewal 
through out life continuously, such as the hair follicles.  
The self-renewal is assured by the presence of multipotent or unipotent 
stem cells and amplifying cells within tissues.These cells are able to divide and 
give origin to new cells that will replace the old or damaged ones. The process of 
cell division is called mitosis. Mitosis can occur in three different ways: 
symmetrically, along the polarity axis, to self-renew; or asymmetrically, 
perpendicularly or with a tilted angle to the polarity axis, in order to create 
differentiated and specialized cells72. Symmetry of cell division is in fact an 
important factor that defines exactly the role and the fate of a new-born cell28. 
Either symmetrical or asymmetrical cell divisions aim to segregate chromosomes 
between two daughters in a directional manner.  
A specific structure in the cell is responsible for the equal separation of 
chromosomes during cell division: the mitotic spindle. This machinery is 
composed of microtubule filaments, nucleated from two spindle poles 
(centrosomes).  
Mitosis starts in interphase, with duplication of DNA and centrosomes, and 
synthesis of many proteins that will be involved in the mitotic process later on.  
During prophase, the chromatin fibers in the nucleus become tightly coiled, 
condensing into chromosomes. Meanwhile, microtubules nucleated by the 
centrosomes approach and contact the nuclear envelope. It is in prometaphase that 
the nuclear envelope collapses, torn apart from dynein directed-MTs, and actin 
fibres73,74. At this stage, microtubules capture chromosomes, align them onto the 
metaphase plate. Metaphase is the moment the cell checks that all the 
chromosomes brought onto the metaphase plate are correctly attached to MTs. 
This would be fundamental for anaphase, when chromosomes will be split 
between the two daughter cells 75. Mitosis ends up with segregation of cytoplasm. 
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This last phase is called citokinesis and relies on the efficiency of a structure 
known as the cleavage furrow. The cleavage furrow is responsible for contractile 
ring constriction, till the complete separation of cytoplasm and membranes.  
Microtubules are not only taking part in chromosome capture, alignment 
and segregation, but in positioning of the mitotic spindle within the cell. A set of 
microtubules, called astral microtubules, is nucleated from the centrosomes and 
directed toward the cell cortex (an actin-rich layer on the inner face of the plasma 
membrane that supports the plasma membrane and it is an responsible for 
movements of the cell surface) where they are anchored at several components of 
cell-cell junctions. It is known that astral microtubules can dock at the AJs via 
p120catenin22 and it was previously reported that depletion of E-cadherin, 
blocking of E-cadherin-E-cadherin complexes via blocking antibodies or 
deprivation of calcium alter spindle positioning and consequentially symmetry of 
cell division76. Several other components of the cell-polarity complex have been 
reported to, if altered, to affect the symmetry of cell division: Par677, Par378, 
aPCK77,78, β-catenin79 and APC80. This suggests that cell polarity establishment and 
maintenance is required for the cells to know which plane they have to divide in, 
in order to guarantee a perfect tissue order. Interestingly, Garrod’s group showed 
already in 1993 by fluorescent microscopy that epithelial junctions (TJs, AJs and 
desmosomes) are retained during the entire process of cell division81. These results 
were further corroborated by electron microscopy confirming the importance of 
cell-cell junctions in the establishment of the polarity plane in dividing cells in 
conjunction with the need of the epithelium of not opening gaps within the layer, 
even while mitosis occurs. In fact, it is known that, during mitosis, mitotic cells 
round up, partially detaching from the substrate by remodelling focal adhesion 
sites interacting with the matrix components. This is thought to help to 
accommodate the shape changes supporting the mitotic spindle and chromosomes 
during separation82. Despite this big change, apical junctions are not disassembled, 
keeping cells close to each other and within the layer, and, thereby, the barrier 
intact83–87. 
 
1.8 Small GTPases regulate cell division 
Since the discovery of their role as actin regulators, smallGTPases have 
been identified as regulators of many cellular processes, as well as cell division. As 
I described in the previous section, cell division is a complicated event that can be 
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split into many steps. Different smallGTPases have been associated with various 
stages of the cell cycle (Figure 1.6). 
The first step of cell division that is regulated by Rho GTPases is entry into 
the cell cycle and G1/S phase progression. They have been demonstrated to 
regulate transcription of genes required for efficient progression of the cell cycle 
and cell division. Among these genes, are those encoding cyclin D1 and p2188. The 
first step of this process, it is the duplication of the centrosomes, in S phase, which 
are fundamental for the nucleation of microtubules during spindle assembly.  
Duplication of centrosomes was reported to be controlled by RhoA and RhoC, via 
ROCKII89,90 
At the onset of mitosis, cells round up. At this level, many reports appeared 
showing the major role of Rho smallGTPases in the organization of cortical actin. 
Cytoskeleton rearranges lead to the changes in cell shape that will be necessary to 
accommodate the bulky structure of the mitotic spindle and chromosomes.  
Increase in RhoA activity during mitosis has been proposed to occur via 
inhibition of p190RhoGAP-A, which is activated upon phosphorylation by Cdk1. 
Active RhoA mediates rounding up during mitosis through its effector ROCK 
(Rho-associated kinase), which activates myosin-II. Overexpression of RhoA leads 
to aberrant cell rounding during mitosis and their detachment from the epithelial 
sheet91,92. 
Later on in prometaphase and metaphase, RhoA or Cdc42 have been suggested to 
play a role in spindly assembly attachment of microtubules to kinetochores. RhoA, 
possibly activated by the RhoGEF Lfc/GEF-H1, binds its effector mDia1 and 
assures correct spindle formation. When Lfc is depleted, cells accumulate in 
prometaphase and mitotic spindles form in an aberrant way93.  
In parallel, Cdc42 signals via mDia3 to microtubules and promoting their 
attachment at kinetochores. It has later been shown that mDia3 binds microtubule 
tips. This process is controlled by Aurora B phosphorylation: when mDia3 is 
phosphorylated by Aurora B, its affinity for microtubules is reduced. Binding of 
mDia3 at the plus ends of microtubules seems to be important in regulating 
microubule dynamics. In fact, expression of a phosphomimetic mutant stabilize 
microtubules against cold-induced disassembly94–96. Considering that mDia3 is an 
effector of Cdc42, this underlines the possibility that Cdc42 controls microtubule 
dynamics via mDia3, in mitosis. 
It is also important that Cdc42 is switched off at the right moment. Cdc42 
activity might be turned off by the MgcRacGAP. During metaphase, MgcRacGAP 
binds the mitotic spindle-associated protein PRC1 and inhibits its GAP function 
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favouring Cdc42 activity. It has been suggested that phosphorylation of 
MgcRacGAP by Aurora B might disrupt the PRC1/MgcRacGAP complex and 
thus de-repress MgcRacGAP activity on Cdc4297. 
At the end of mitosis, chromosomes are segregated between the two 
daughter cells and the cleavage furrow contracts to separate the plasma 
membrane and cytoplasm of the two daughter cells. It is in this phase, called 
citokinesis, that the last membranous connection known as midbody is cleaved to 
release the two daughter cells98,99. It seems that Ect2 is recruited at the midzone in 
a Plk1-dependent manner, here it activates RhoA for the contraction of the 
actomyosin ring and the final cleavage of the midbody100,101. Ect2 activity is 
specifically limited at this stage by Cdk1 that phosphorylates Ect2 preventing the 
activation until after the onset of anaphase. In addition, Ect2 is regulated by 
association with MgcRacGAP. Once again it is Plk1 that phosphorylates 
MgcRacGAP to promote its interaction with Ect2 and Ect2 recruitment to the 
spindle midzone102. 
 
 
 
Figure 1.6 Role of smallGTPases in mitosis 
Schematic cartoon of mitosis. Before entering mitosis, a cell duplicates DNA and centrosomes in 
interphase. Mitosis starts with the condensation of DNA in chromosomes and the nuclear envelop 
breaking-down. Chromosomes are captured in prometaphase, aligned onto the mitotic plate in 
metaphase and finally segregated in anaphase. The end of mitosis occurs with the separation of 
citoplasms between the two daughter cells in citokinesis.  
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Small GTPases play an important role throughout the different phases of mitosis. In the grey box 
are listed RhoGTPases that have been found involved in a particular mitotic phase and if 
regulators or effectors have been reported too.   
1.9 Discovery of DLCs, GAPs for Cdc42 and RhoA 
In, 1998, Yuan and colleagues indentified a segment of genomic DNA  
underrepresented in human hepatocellular carcinoma (HCC).62 This frangment 
contains a gene frequently found lost in HCC samples and HCC cell lines. (HCC). 
For this reason the gene was called Deleted in Liver Cancer 1 (DLC1). Sequencing 
of DLC1 cDNA showed that it was the human orthologue of the rat p122RhoGAP 
protein, characterized by Homma and Emori as containing a 200 amino acids 
region responsible for RhoGAP activity103. The ArhGAP7/DLC1 gene is localized 
on chromosome 8p21-22 and encodes a 1091-amino acid protein with a predicted 
molecular mass of 122 kDa. There have been annotated different transcripts for 
DLC1: a long isoform, and a short one, lacking a portion of the N-terminus 
domain containing a protein-protein interaction domain (SAM). In mouse, there 
are two similar transcripts for DLC-1, suggesting that the biological relevance of 
the two isoforms is conserved.   
DLC2 was identified in 2003 on chromosome 13q13 by analysis of genomic 
and cDNA sequences as a gene that encoded a RhoGAP domain protein related to 
DLC1, containing 1113-amino acid residues and encoding a protein with a 
molecular weight of 125 kDa. DLC2 is also expressed as different transcripts: as 
DLC1, there is a long isoform called DLC2α and a N-terminally truncated one 
called DLC2γ; in addiction, a quite different isoform has been reported, containing 
an alternatively spliced exon at its N-terminus  (DLC2β).  In mouse, there is a gene 
mapped to chromosome 5G3, which encodes a protein that is 90% identical to 
human DLC2104.  
Few years later, a gene on chromosome Xq13 was discovered in a screen of 
cDNA clones isolated from a human myeloid cell line library. From the analysis of 
this gene, it became evident that it encodes a protein of 1103 amino acids with a 
calculated molecular mass of 121 kDa. Due to its homology with DLC-1 and DLC-
2, it was termed DLC3105.  DLC3 exists in two isoforms: DLC3α, a long isoform, 
and DLC3β lacking the SAM domain at the N-terminus. The gene encoding DLC3 
was mapped to the mouse chromosome X. 
DLC1, DLC2 and DLC3 form the Deleted in Liver Cancer protein family. 
Despite of their original name, they have many times characterized as tumour 
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suppressors not only in liver cancer, but also in various other types of cancer such 
as breast, lung, ovary, kidney, colon, stomach, prostate and nasopharynx. All 
these reports highlighted the importance of investigating how DLCs alteration 
triggers cancer initiation. In fact, it is still poorly understood how DLCs act as 
tumour suppressors. 
 
1.10 DLCs structure 
Along the protein sequence of DLCs four distinct domains have been 
identified: the sterile α motif (SAM) at the N-terminus, a serin-rich region, a 
conserved RhoGAP (GAP) domain and the steroidogenic acute regulatory-related 
lipid transfer (START) domain at the C-terminus (Figure 1.7).  
The N-terminus of the DLCs contains a SAM domain, a motif of about 70 
amino acids discovered in more than 200 human proteins, including transcription 
factors and signalling proteins106. The main function of the SAM domain is 
thought to be mediating protein–protein interactions, but certain SAM modules 
have been reported to bind RNA and lipids. Some SAM domain proteins are able 
to interact with other SAM domains to form oligomers or multi-protein 
complexes, respectively. In 2007, the structure of the SAM domains of the DLC 
family proteins was published and described as having some unique features: in 
particular, the SAM domain of DLC-2 shows to form a four α−helical bundle, 
instead of the usual five helices typical of other SAM domains107,108. This domain 
exists in solution as a monomer and it may interact with a lipid ligand. The fact 
that in the case of all the three DLCs, one of the isoforms does not contain the 
SAM domain raises the possibility that biological properties might be different 
from the full length versions. An intriguing idea is that the SAM domain is an 
autoinhibitory domain for RhoGAP catalytic activity109. The four helixes of the 
DLC1 SAM domain are able to bind EF1A1, a factor increased in a wide variety of 
human cancers, including pancreas, lung, prostate, breast, colon and 
melanomas110. EF1A1 can regulate the actin network through its G-actin- binding 
and F-actin-bundling activity, and is able to stabilize microtubules, controlling cell 
migration and cell growth.  
The region between the SAM and RhoGAP domains has the least sequence 
conservation among the DLCs, but alignment of this segment reveals short 
stretches of high similarity separated by gaps and insertions of variable length. 
This region is rich in serine residues that have been proposed as potential sites for 
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phosphorylation by serine-threonine protein kinases, possibly as a regulatory 
mechanism. An interesting site already characterized is Ser322 of rat p122RhoGAP 
(equivalent to Ser329 in human DLC1): this site is phosphorylated in rat 
adipocytes after insulin treatment. A cluster of 7 phosphorylation sites in rat DLC1 
(equivalent to human Ser304, Ser305, Ser310, Thr312, Ser313, Ser 317 and Thr318) 
was found as phosphopeptides in vasopressin-treated rat kidney cells111. In a 
proteomic analysis of phosphorylated peptides in mouse liver Ser89 of DLC1 and 
an equivalent residue in DLC2 (Ser133 in the human sequence) were identified as 
phosphorylation sites112. An additional site was found in DLC2 (corresponding to 
Ser572 in the human protein), which seems identical to Ser572 in DLC1 and DLC3. 
Another interesting feature of this middle region is the presence of several proline-
rich segments that could bind to proline recognition domains, such as the SH3 (src 
homology 3) domains present in many signalling proteins113. To support this 
hypothesis, the secondary structure of this region has been presented as a globular 
domain with flexibility and the ability to harbour multiple sites for interactions 
with other molecules. 
The RhoGAP domain is the most highly conserved domain among the three 
DLC family members and has around 70% sequence identity. It is known that the 
intrinsic GTP hydrolysis rates of Rho proteins are low, and the role of GAP 
domains is to enhance the GTPase activity, by positioning the catalytic glutamine 
residue in the GTPases so that the nucleophilic water molecule would is aligned 
(and will attack the γ-phosphate of GTP114,115. Hence, GAPs promote GTPase 
activity via arginine residues that act like fingers that enter in the catalityc GTPase 
site, introducing a positive charge that stabilizes the transition state and, thereby, 
facilitating GTP hydrolysis. All of the DLC proteins have a conserved arginine 
residue corresponding to Arg677 of human DLC1116. Rat p122RhoGAP and human 
DLC1, DLC2 and DLC3 were found to have a specific preference for RhoA and 
Cdc42 over Rac-1. 
At the C-terminus of DLCs is a domain of about 200 amino acids. This so-
called START domain is a domain first identified in several proteins with a role in 
lipid transport or lipid metabolism (StAR and MLN64 bind cholesterol, and play a 
role in lipid transport into mitochondria)117.  Up to today, the START domain has 
been found in 15 human proteins and for some of them the 3D structure was 
resolved. The STARD domain contains a hydrophobic tunnel formed by a curved 
9-stranded β-sheet118. The role of the START domain within DLCs is not clear. It 
has been proposed that it may regulate subcellular localization and activity, as 
other lipid-binding found in other RhoGAP proteins, such as the Sec14 domain in 
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Cdc42GAP119. It has even been proposed that apart from lipids, START domains 
may bind corticosteroids, hence it may bind hormones and confer hormone-
regulation. This is only a speculation, however, but it may be important for the 
biological functions of DLCs. 
 
 
 
Figure 1.7 DLCs family, structure and KO mice phenotype 
Shown is a schematic representation of the structure of human DLCs. Domains are indicated along 
with the percentage identity to the corresponding domains of human DLC1.  
 
1.11 Tissue distribution and loss of function in mice and drosophila 
DLC1 mRNA is widely expressed in various human and mouse tissues and 
at various stages of development, as shown by Northern blot hybridization 62,120. 
The distribution of the DLC2 and DLC3 mRNAs appears to overlap with that of 
DLC- 1 in many adult tissues 104,105.  
Since the distribution is so wide, a KO approach in mice seems very helpful 
to explore the biological function of DLCs. Up to today, there have been reported 
KO mice strains for DLC1 and DLC2, but not DLC-3 (Fig 1.7). Lack of DLC1 leads 
to embryonic lethality. DLC1 homozygous for the mutant allele do not survive 
beyond 10.5 days of gestation. Histological examination of 9.5-day DLC1 -/- 
embryos revealed that these mice have an open anterior neural tube, show 
abnormalities in the branchial arches, brain neuroepithelium and heart, and 
defective foetal blood vessels in the placental labyrinth121. Apparently, DLC2 and 
DLC3 gene products were unable to compensate for DLC1 deficiency during 
development. Analysis of fibroblasts from 9.5 day DLC1-/-embryos indicates that 
they were able to proliferate in culture and they show a reduction in actin stress 
fibres and vinculin-containing focal adhesions. On the contrary, over-expression of 
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DLC1 in cultured cells disrupts focal adhesions and actin stress fibres122. Despite it 
might seem a contraction, the fact that lack of DLC1 and its overexpression lead to 
similar response, could be due to the fact that immortalized cell lines are a very 
different system from an organism and some responses might have been altered 
by the immortalization process123.  
In contrast, DLC2 KO is not lethal and mice appeared normal and healthy, 
indicating that DLC2 is not required for embryonic development and mouse 
survival. Analyis for the microvascular density and morphology in stomach, 
skeletal muscle, brain did not reveal any difference between WT and KO mice124. 
Since DLC2 mRNA distribution shows that DLC2 is highly concentrated in 
endothelial cells, scientists investigated the role of DLC2 in angiogenesis. 
Subcutaneous injection of matrigel in WT and KO mice to induce 
neovascularization revealed that the formed matrigel plugs from the KO mice 
appeared bloodier and had a higher hemoglobin concentration than those of WT 
mice, and had also a higher population of CD31 positive cells in plugs. 
Experiments of DLC2 KO mouse aorta sections grown in a 3D matrigel culture 
showed an increase in sprouting in DLC2 KO samples, again indicating that DLC2 
may modulate angiogenic responses of endothelial cells. 
Interestingly, studies in Drosophila deficient for the homologue of DLCs 
show similar results to DLC1 KO mice phenotype: embryos develop multiple 
defects in various tissues during morphogenesis, including the Malpighian 
tubules, midgut, head, posterior spiracles and the epidermis during dorsal closure 
In the Drosophila genome, there is only one DLC-1-like protein, RhoGAP88 C, 
encoded by the gene crossveinless-c (cv-c)125. RhoGAP88 C protein has the SAM -
GAP-START domain organization and has 40% identity with DLC-1 and DLC-2 
and 36% identity with DLC3126. 
An RNA interference study specific for RhoGAP genes identified 
RhoGAP88C as essential for viability. When RhoGAP88C mutants were analysed 
in search of a phenotype, it was evident that cv-c is fundamental for actin 
cytoskeleton dynamics during morphogenesis, as the mutant strains revealed 
delayed dorsal closure of the epidermis and defects in head involution. This 
resulted in a loss of the posterior crossvein and detachment of the anterior 
crossvein in the wings of adult flies. By molecular characterization of embryonic 
lethal alleles two null alleles resulted from nonsense mutations, and a third (cv-c7) 
had a missense mutation (Arg601Gln) that, interestingly, targets the ‘arginine 
finger’ of the RhoGAP domain127.  
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1.12 DLCs and cancer  
After the discovery of DLC1 as a tumour suppressor gene in hepatocellular 
carcinoma62, down- regulation of DLC1 was observed in a wide range of primary 
tumour tissues, including liver, breast, lung, ovarian, kidney, colon, stomach and 
prostate, or in cancer cell lines derived from breast cancer metastasis121,128–131. The 
under-expression of DLC1 has been shown to be due to either heterozygous 
deletions of the DLC1 gene or hypermethylation of its gene promoter132–134. Also 
DLC2 and DLC3 genes were shown to be involved in human neoplasm 
development. DLC2 was found to be downregulated in breast, lung, ovarian, 
renal, uterine, gastric, colon, rectal and liver tumors 105,135–137(figure 1.8).  
Notably, from the individual DLCs mutation frequency of mutation in 
HCC cell lines it results that DLC2 is more frequently downregulated than 
DLC1130.  
How DLCs act as tumour suppressor genesis still poorly understood. 
Misregulation of DLC1 was shown to be associated with increased proliferation, 
cell migration and invasion, and induced apoptosis. There is evidence that this 
may be due to the RhoGAP activity. I mentioned above that DLC1 was shown to 
work as GAP for RhoA and Cdc42. DLC-1 was shown to negatively regulate the 
Rho/ROCK/MLC pathway in HCC cell lines in a RhoGAP-dependent manner, 
regulating actomyosin contractility. In fact, ectopic expression of DLC1 abrogates 
Rho/ROCK-mediated cytoskeletal stress fibres and focal adhesions by 
downregulating cortical phosphorylation of myosin light chain 2 (MLC2). 
RhoGAP- deficient mutants of DLC1 (DLC1 K714E) abolished these inhibitory 
events122.  
Another model of DLC-1 function proposed focuses on focal adhesions, 
where it has been shown to localize. Here, DLC-1 is thought to bind the tensin 
(mediator of actin fibres and focal adhesions plaques) SH2 domain. Disruption of 
this binding via a point mutation of a critical tyrosine residue (Y442F) in DLC1 
does not alter the capability of DLC-1 to downregulate intracellular RhoA activity 
but compromises the integrity of focal adhesions with deleterious consequences 
for the cells. This results suggest that DLC1’s biological activity might depend not 
only on the GAP functions, but also on the cooperation between DLC1 and its 
partners131,138  
DLC2 was first reported as a gene encoding a RhoGAP protein that can 
inhibit transformation in Ras-transfected fibroblasts.  Subsequently, it was shown 
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that ectopic transfection of DLC2 is able to inhibit growth in MCF-7 breast cancer 
cells139. Also transfection of DLC2γ can suppress growth in soft agar and RhoA 
activity in HepG2136. Inactivation of RhoA leads to cell morphological changes, 
from angular shapes to round ones, by deregulating focal adhesions.  Another 
way by which DLC2 could act as a tumour suppressor was proposed by Leung et 
al in 2010:  DLC2 may effect cell proliferation by controlling cell cycle progression. 
In fact, when DLC2γ is over expressed, an arrest in G1 cells is seen. This was 
shown to correlate with a misregulation of ribosomal kinase p7S6K 
phosphorylation. DLC2γ overexpression prevents p7S6K phosphorylation, a 
downstream target of ERK1/2 and resulted in a G1 phase arrest135.  
DLC-3 is the most recently discovered member of the DLCs and not much 
information is available about it. When it was identified for the first time in 2007, 
DLC3 was noted to be able to bind tensin, as well as DLC-1. A possible 
mechanism hence depicts DLC3 as acting as DLC-1 does in the regulation of focal 
adhesions, cell shape and morphology, but this has not been proven138.   Recently, 
DLC3 has been proposed to localize at epithelial cell–cell contact sites, in 
particular adherens junctions140. I described before how stability of cell-cell 
junctions is regulated by a balanced and highly localized activity of Rho GTPases. 
Holeiter et al. have shown that DLC3 depletion leads to mislocalization of E-
cadherin and catenins and results in impaired cell aggregation and increased 
migration. This could be explained by aberrant local Rho signalling because 
ROCK inhibition restored cell–cell contacts in DLC3 knockdown cells.  
 
 
 
Figure 1.8 Table of DLCs features in cancer 
The table reports names of proteins (yellow box), a list of types of cancer tissues DLCs have been 
found mutated (orange box), with corresponding reference (grey box). In the green box, proposed 
mechanisms of action are listed for all the DLCs proteins, and the corresponding references are in 
the following grey box. 
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1.13 THE AIM OF THIS THESIS 
 
The general goal of my thesis is to shed light on the mechanism by which 
DLC2 acts as tumour suppressor. As I discussed above, it is not entirely 
understood how DLC protein misregulation leads to cancer initiation and 
metastasis. In chapter three, I describe how DLC2 was identified with an siRNA 
screen designed to investigate small GTPase regulators and effectors involved in 
the regulation of cell-cell junctions in epithelial cells. I also describe how further 
analyses revealed that DLC2 not only regulates cell-cell contacts but also the 
mitotic spindle. Based on the data I obtained at the beginning of my thesis, I 
formulated the following specific aims.  
. 
1. To determine in which pathway DLC2 acts in and how it regulates 
Rho GTPase activity during mitosis 
 
2. To identify forces altered in the mitotic spindle that could explain 
the DLC2 depletion phenotype observed. Taking advantage of 
knowledge available in literature, I have decided to investigate what 
is the role of Kif1B in DLC2 pathway and how this motor protein is 
affected by DLC2 depletion. 
 
3. To understand how the mitotic spindle shape and functionality is 
altered upon DLC2 or Kif1B depletion.  
 
4. To identity the Cdc42 effector that functions downstream of DLC2. 
 
5. To determine how DLC2 regulates microtubule dynamics. 
 
6. To test if DLC2 is required for faithful chromosome separation and 
maintenance of genome integrity. 
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MATERIALS AND METHODS 
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CHAPTER 2: MATERIALS AND METHODS 
2.1  DNA PURIFICATION AND BACERIA CULTURE  
2.1.1 Bacteria Transformation and DNA purification 
CaCl2 competent bacteria (E.coli strain DH5α) were thawed on ice. 1.7 µl of a 
1.4M β-mercaptoethanol was added to 100 µl of bacteria and incubated for 10’. 10 
ng of plasmid DNA was added to each 100 µl and mixed by pipetting up and 
down once. The bacteria were left to incubate on ice for 30 minutes, heat shocked 
for 45 seconds at 42°C and immediately put back on ice for 3 minutes. 900 µl of LB 
medium was added and the tube was incubated for 90 minutes at 37°C. 100 µl of 
the LB bacteria suspension were plated onto LB agar plates containing 100 µg/ml 
Ampicillin or 50 µg/ml Kanamycin, but in the case of ligation transformation cells 
were spun down for 1 minute at 13000 rpm and the pellet was resuspended in 100 
μl of medium and plated. The plates were placed at 37°C and the bacteria left to 
grow overnight. 
To purify plasmid from bacteria, a single bacterial colony transformed with 
the appropriate plasmid was picked using a sterile pipette tip and placed into 5ml 
of LB containing 100 µg/ml Ampicillin or 50 µg/ml Kanamycin for mini or 200 ml 
for midi preps. The cultures were left to grow overnight in an incubator at 37°C 
with shaking at 220 rpm. The following day the bacteria were centrifuged at 4000 
rpm for 20 minutes and processed according to the standard Qiagen protocols. 
The plasmid DNA was resuspended in 10 mM Tris pH 8.5 0.1 mM EDTA (TE 
buffer). Concentrations and purity of plasmid DNA samples were determined 
with a spectrophotometer (Themo Scientific Helios β) to measure the absorbance 
of samples at wavelengths of 260 nm and 280 nm. 
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2.1.2 DNA agarose gel electrophoresis 
1 % agarose gels were prepared by dissolving 1 g of Low Melt Clone 
Agarose (AGTC BioProducts) in 100 ml of TAE buffer (40 mM Tris-acetate, 1 mM 
EDTA pH 8.0), or 1 g of Agarose, Molecular Grade (BIOLINE) in TBE buffer (0.89 
M Tris Borate pH 8.3 + 20 nM Na2EDTA). SafeView (NBS Biologicals Ltd) was 
added prior to gel pouring. 6X DNA loading buffer (30% glycerol (v/v), 0.25% 
bromophenol blue (w/v), 0.25% xylene cyanol (w/v)) was added to DNA samples 
to achieve a final concentration of 1X DNA loading buffer. Samples were typically 
run at 70-90 V for approximately 1 hour and 30 minutes. DNA bands were 
visualized using a UV transilluminator. 
 
2.1.3 Polymerase Chain Reaction (PCR) 
Standard PCR to amplify fragments for sub-cloning was carried out using 
100 ng of template plasmid DNA and 40 pmol of each primer (Eurofins/MWG see 
table) reactions were carried out in 50 µl total volume using 1 µl (2.5 Units) of 
Expand high fidelity polymerase (Roche Applied Science) and 200 µM of dNTP 
mix (Roche Applied Science). Where necessary 10% DMSO was added to the 
reaction mix. Reactions were carried out in a (PCR machine) using a typical 
program such as: 
1  94°C for 2 minutes 
2  94 °C for 30 seconds 
3  67°C for 45 seconds 
4  72°C for 1 minute / 1 kB 
5  Step 2 for X25 cycles 
6  72°C for 10 minutes 
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2.1.4 Restriction enzyme digests, DNA purification from gel and 
ligations 
5µg plasmid DNA or PCR products were digested in a total volume of 30 
µl, using 0.5 µl of the appropriate restriction enzymes (New England Biolabs) in 
the provided and recommended buffer solutions. Reactions were incubated at 
37°C for 1 hour. Digested DNA fragments were purified by running on agarose 
gels, excising the appropriate bands under a long wave length UV 
transilluminator. To purify the DNA, 1ml of 6M solution of Sodium Iodide was 
added to the excised agarose bands and the agarose was melted at 70°C for 10 
minutes. 50 µl silica beads (Sigma) were added to bind DNA. To help the binding, 
tubes were inverted every 5 minutes. Samples were then washed twice with silica 
wash buffer (50 mM NaCl, 10 mM Tris HCL pH 7.5 2.5 mM EDTA, 50% v/v 
Ethanol). DNA was eluted from the beads in 30 µl of 10 mM Tris pH 8.5 0.1 mM 
EDTA (TE buffer). 
Ligations were carried out using a 1:3 molar ratio of Vector: Insert in a 
volume of 20 µl, using 1 µl (5 units) of T4 ligase (Roche) in the provided buffer. 
Reactions were incubated overnight at 4°C, left at room temperature the 
day after for 2 hours. The whole volume was used to transform 100 µl DH5a E.coli. 
 
2.1.5 Mini and midi: DNA extraction from bacteria 
Mini and Midi protocols were performed in accord to the kits from NBS.  
For the analysis of ligations, Mini preps were performed from 10-15 
colonies for each construct to find the right clones. They were inoculated the night 
before in a 5ml LB solution and let to grow at 37oC overnight with 200 rpm 
shaking. For Midi preps, single colonies were picked and grown overnight at 37oC 
with 200rpm shaking.  
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2.2  CELL CULTURE AND CELL TREATMENT  
2.2.1   Cell lines: culture, freezing and thawing  
Human Cornel Epithelial cells (HCE), transformed with SV-40 large T-
antigen were a gift from Chang M.S. (Vanderblit, University, Nashville, 
Tennessee). HeLa H2B-GFP/α-tubulin-mRFP and HeLa EB3–tdTomato eGFP–
CENP-A cell lines were a gift from Patrick Meraldi (University of Geneva, 
Switzerland). HeLa Mad2-GFP cells line was a gift from Helder Maiato’s lab, 
University of Porto, Portugal. 
 HeLa and HCE cells were cultured in DMEM medium containing 10% 
heat-inactivated FBS with 100ug/ml penicillin/Streptomycin (PAA cell culture), at 
37°C and in 5% CO2 atmosphere. 
For storage, cells in 6 wells-plates were frozen by trypsinizing for 15 
minutes at 37oC with 0.5 ml of 1X Trypsin. Cells were centrifuged at 1000 rpm for 
5 minutes, and then re-suspended in freezing medium (DMEM containing 10% 
DMSO and 20% FBS). 
For defrosting, cells were thawed, washed once with DMEM, every time 
centrifuging for 5 minutes at 1000 rpm. Then, the cells were plated in the 
appropriate medium.      
 
2.2.2   Lipofectamine 2000 transfection of DNA 
For transient transfection, Lipofectime 2000 (Invitrogen) was used.  For 48-
well plates, 1 ul of Lipofectime was mixed with 0.5 ug of DNA in a final volume of 
50 ul of OptiMEM medium (Gibco/Invitrogen).  Transfection tubes were left at 
room temperature for 30 minutes and then added to 80% confluent cells. After 4 
hours, medium was changed with fresh DMEM. Cells were processed 16 hours 
later.  
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Table 2.1 List of DNA construct used in this project 
 
2.2.3   SiRNA transfection 
4 siRNA specific for human DLC2 mRNA were initially purchased from 
Dharmacon (siGENOME), and tested by WB and IF, by comparing their effect to a 
non-specific control siRNA.  The fourth was discarded on the basis of the 
efficiency and the α-tubulin levels since it was toxic.  
For siRNA transfections, I used INTERFERin (Polyplus transfection). A 
single six well plate at 90% confluence was trypsinised and diluted 1/60 for WB 
and 1/90 for IF. 0.5 ml per well of 48-well plate was used. Transfection was carried 
on the same day for HCE cells, the day after for HeLa cells. Transfection mix was 
prepared with 1 µl INTERFERin (Polyplus transfection), 0.5 µl of 20 mM siRNA in 
50 µl OptiMEM (Gibco/Invitrogen). The mix was left at RT for 30 minutes. 50 µl of 
transfection mix was added to each well of the 48-well plate. Medium was 
replaced the day after, and cells were left for a total of 96 hours before either 
fixation or protein extraction.   
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Table 2.2 List of siRNA used in this project 
 
 
2.2.4   Cell Synchronization   
Cells were incubated with Nocodazole 100µM  (1:30000 from stock 3mM) 
for 6h as described in the reference141. 
To perform the wash off, cells were rinsed twice with normal DMEM and 
then incubated with fresh DMEM/FBS/P/S.  Cells were harvested or fixed and 
stained at the following time points: 45’ for the metaphase/anaphase peak, or 90’ 
for the telophase/cytokinesis peak141,142. 
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2.2.5   Microtubules stabilization assay  
To stabilize microtubules, Taxol 0.5µM (1:20000 from a stock 10mM) was 
incubated with the cells ON at 37C. Cells were fixed and stained the day after as 
indicated in the microscopy section. 
 
2.2.6   M Check-Point inhibition via MPS-1 
To test the hypothesis that the delay in metaphase is check-point 
dependent, cells were treated with 200µM MPS-1 inhibitor. The inhibitor was 
added to the cells at 37oC, right before filming.  
 
2.2.7   Monopolar spindle formation and wash-out 
To induce formation of monopolar spindles, cells were treated with 
monastrol 100µM (Sigma-Aldrich) 2h at 37°C143. The last hour, MG132 was added. 
Cells were then washed 3X with fresh medium and let to rearrange bipolar 
spindles. Time points analyzed were 0’, 20’, 60’ and 90’. Over 60 cells were 
analyzed per conditions144,145. 
 
2.2.8   Aurora B inhibition 
HCE cells were treated with ZM447439 (Tocris Bioscience) ON at 37oC at 
the final concentration of 3µM. Cells were afterwards fixed for further 
analyses146,147. 
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2.2.9   K-fiber disassembling 
The aim of this experiment is to test the stability of K-fibres. Treating cells 
with cold triggers the disassembly of these fibers. Cells were put on ice and were 
then fixed at the following time-points: 0’, 10’, 15’, 20’, 25’ and 30’. To compare 
Control and DLC2 KD/ Kif1B KD/Cdc42 KD/mDia3 KD cells, cells were 
arranged in classes. For the experiment that regards control/DLC2 KD/Kif1B KD 
cells, the three classes for quantification purposes were: regular mitotic spindles, 
spindle with short K-fibres, long fibres and chromosome misalignment. On the 
contrary, for the experiment with control/Cdc42 KD/mDia3 KD cells, the four 
classes for quantification purposes were: regular mitotic spindle, spindle with 
short K-fibres, short fibres and chromosome misalignment148.  
 
2.2.10 Chromosome spread 
Chromosome spreads were performed by treating HCE cells for 2 h with 
nocodazole (3.3mM diluted 1:1000) at 37ºC. and then incubated for 20 min in 75 
mM KCl nocodazole (3.3mM diluted to 1:1000) at 37ºC to induce hypotonic shock. 
Cells were rinsed with 1X PBS and then fixed first with methanol -20ºC for 3’ and 
then PFA 4% diluted in PBS for 20’ at RT. Cells were blocked with 
PBS/0.01%Triton/10%FBS. To quantify the number of chromosomes present in 
chromosome spreads, CREST was used to stain the kinetochores. Kinetochore 
pairs through z-sections were counted in a minimum of 50 cells for each 
condition143,149,150. 
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2.3  PROTEIN ANALYSIS 
2.3.1  Western blotting 
Protein lysates were prepared for SDS/PAGE analysis by washing cells 
twice with 1X PBS and then adding a buffer made of one part 3X sample buffer 
(6% SDS, 30% glycerol, 0.003% bromophenolblue, 0.3 M DTT, 0.1875 M Tris/pH 
6.8) and 2 parts distilled water to give a final 1X concentration of sample buffer. 20 
mM DTT and 6 M urea were used to help the denaturing of proteins. After three 
times homogenization with a 23 gauge micro-needle, samples were heated at 
100°C for 10 minutes. 
8% or 10% polyacrylamide gels were prepared few days in advance, using a 
MightySmall minigel electrophoresis system.  The separating gel contained 5% 
Tris pH 8.8, 0.1% SDS, 0.1% APS, TEMED and distilled water. Stacking gel 50 ml 
was made with 5% Tris pH 6.8, 0.1% SDS, 0.1% APS, TEMED and distilled water. 
Samples were loaded on the gels and run at 25 mA per gel, for 45 minutes. 
Gels were transferred using a standard transfer apparatus (BioRad) using 
transfer buffer containing 25 mM Tris, 250 mM glycine pH 8.3 0.1% SDS, 20% 
MeOH. The nitrocellulose membrane (Santa-Cruz) was mounted with the gel in 
the apparatus, and the transfers were  run for 2 hours and 30 minutes at 4°C at 100 
V constant and 0.45 mA.  
After the transfer, the membranes were stained with Amidoblack dye 0.1% 
for 30 seconds, then de-stained with (20% MeOH 7.5% acetic-acid) for 30 minutes, 
washed with PBS-0.2%Tween-20 for 30’ and blocked in the blocking solution (5% 
Milk in PBS-0.2% Tween-20-0.1% NaN3) for 30 minutes with agitation. The 
membrane was then incubated overnight at 4°C on the shaker with the 
appropriate primary antibody, diluted in the blocking solution.  
The day after the membranes were washed three times for 10 minutes with 
PBS 0.2% Tween-20 solution and then incubated with the appropriate horseradish 
peroxidase conjugated secondary antibodies diluted in PBS 0.1% Tween-20 for 1 
hour. The membranes were washed three times for 10 minutes with PBS 0.1% 
Tween-20 solution and another three times with PBS for 5 minutes. Membranes 
were soaked in a solution of enhanced chemiluminescence detection system 
(reconstituted from individual products obtained from Sigma), and left in the dark 
with an x-ray film. 
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2.3.2 Immunoprecipitations 
Cells were plated in a 14 cm plate and when they reached confluence, they 
were extracted at 4°C using 2 ml of Triton X100 0.5% PBS. A cocktail of protease 
inhibitors  (10 µg/ml leupeptin, 10 µg/ml aprotinin, 10 µg/ml pepstatin A 50 
µg/ml benzamide and 1 mM PMSF) and phosphatase inhibitors (10 mM sodium 
fluoride (NaF), 10 mM sodium pyrophosphate and 4 mM sodium orthovanadate) 
was added to the lysis buffer prior to extraction. The samples were spun down 2 
minutes at 4°C. To reduce the nonspecific binding, 100 µl of inactive sepharose 
beads were incubated with the extracts for 30 minutes. Samples were spun again 
at 7000 rpm for 2 minutes and the supernatants were transferred to 2 µg of 
antibody left overnight conjugating to Protein G sepharose beads. After incubating 
at 4°C for 2 hours, the beads were washed twice with 1 ml of 0.5% Triton X100 PBS 
and once with PBS. 
To detach proteins form the beads, 60 µl SDS-PAGE buffer containing 20 mM 
DTT and 6 M Urea were added to the samples before boiling for 10 minutes at 100°C. 
 
2.3.3 RhoGTPase activation assay G-LISA 
For these assays, the cells were transfected with the appropriate siRNAs in 
12 well plates, and analysed for levels of active RhoA, Cdc42 and Rac1 using the 
respective G-LISA assay kit from Cytoskeleton Inc. Protein concentrations were 
measured in order to load equal amounts of samples. Protein concentration and 
HRP conjugated secondary antibodies were measured by absorbance at 490 nm 
using a FLUOstar OPTIMA microplate reader (BMGLabTech, Offenburg, 
Germany). 
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2.4  MICROSCOPY 
2.4.1 Immunostaining and confocal microscopy 
Hela cells were grown for 5 days and HCE cells for 4 days on glass cover 
slides in 48 well plates. On the last day, cells were fixed with cold methanol (-
20°C) for 10 minutes in the freezer. Methanol was discarded and cells rehydrated 
with 1XPBS for 5 minutes, then blocked with PBS-0.5%BSA-0.1%NaN3 for 15 
minutes at room temperature. For actin staining, cells were fixed with 3% PFA in 
PBS, pH 7.4 for 20 minutes at room temperature, permeabilised with 0.5% Triton 
in PBS-BSA for five minutes and then incubated with 0.5% BSA 20mM Glycine 
PBS for 5 minutes. For microtubules staining, cells were pre-fixed at 37°C for 15’ 
with PFA 4% diluted in a microtubules stabilization buffer (NaOH-Pipes ph 6.8/ 
MgCl2 1mM/EGTA 1mM/0.1%Triton/H2O). Then they were left a -20°C in 
methanol for 3’. Methanol was discarded and cells rehydrated with 1XPBS for 5 
minutes, then blocked with PBS-0.5%BSA-0.1%NaN3 for 15 minutes at room 
temperature.  
Primary Antibodies were diluted in PBS-0.5%BSA-0.1%NaN3 and incubated 
1 hour at room temperature.  After washing twice with PBS, secondary antibodies 
conjugated FITC, Cy3 or Cy5 (Jackson ImmunoResearch Inc) were added (dilution 
1:300) and cells were kept in the dark for 1 hour.  
For actin staining, 1:2000 fluorescently labelled Phalloidin (Sigma) was 
mixed with the secondary antibodies. For DNA detection Hoechst 33258 
(Invitrogen) was diluted 1:5000 in the secondary antibodies solution. Cells were 
then washed twice with PBS and mounted on microscope slides with ProLong 
antifade mounting medium (Molecular Probes). Slides were observed with a Leica 
DMIRB fluorescent microscope using a 63X objective and processed with Adobe 
Photoshop version 7.0. For confocal microscopy, or a Leica TCS SPE confocal 
microscope using Leica Application Suite (LAS) software. For confocal microscopy 
a 63X objective was used. 
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Table 2.3 List of antibodies used in this project  
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2.4.2 Time lapse microscopy 
For live cell imaging experiments, cells were plated into 35 mm glass 
bottom microwell (14 mm, No 1.5 coverglass) dishes (MatTek Corporation) and 
transfected with siRNAs as described in previous sections. Medium was replaced 
at least 6hours before filming with L-15/10% FBS. Four-dimensional datasets were 
acquired with a spinning disc confocal system (Yokogawa) equipped with an 
electron multiplying charge-coupled device camera (iXonEM+; Andor) and a CSU-
22 unit (Yokogawa) based on an inverted microscope (TE2000-U; Nikon). Two 
laser lines (488 and 561 nm) were used for near-simultaneous excitation of GFP 
and mRFP, and the system was driven by NIS Elements 3.0 software (Nikon). 
Time-lapse imaging of z stacks with 0.7 µm steps covering the entire volume of the 
mitotic apparatus were collected every 2 or 3 min with a plan-apochromat 1.40 NA 
60x immersion oil objective142. Phase contrast microscopy was performed on a 
Nikon Eclipse TE2000-U microscope driven by NIS Elements 3.0 software with 63x 
or 100x objectives. Time-lapse was performed every 30sec, 1min or 2min, 
depending on the type of experiment. 
 
2.4.3 Quantitative analysis of spindle angle and length, astral and 
kinetochores fibre length, and fluorescence intensity 
Quantification of spindle angles and length was performed using ImageJ. 
Images were collected by taking z-stacks with a step of 0.01 µm covering the entire 
volume of the mitotic spindle, for the angle measurements, every 0.5 um for the 
length analysis. Mitotic spindle length was calculated as distance between the two 
spindle poles. The angle between the spindle axis and the substrate was defined as 
the angle between a line parallel to the substrate and the line crossing the two 
spindle poles. 
Length of microtubules was measured in monastrol treated cells. Cells were 
stained with markers specific for astral or kinetochore fibres, then, pictures were 
take with confocal microscopes and finally analysed in ImageJ. Length was 
measured from the spindle poles grouped in the middle of the monopolar spindle 
to the end of the visible fibre. Pictures were maximum intensity projections of 
0.5µm step stacks covering the whole cell height.   
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Aurora B target fluorescence intensity analysis was performed by selecting 
5 kinetochore areas, repeated over 10 pictures. Background was subtracted to the 
intensity mean. Normalized values were compared among control and 
knockdown conditions. The maximum value in control was identified and used as 
a threshold to define how many kinetochores show higher intensity in the 
knockdown cells.  
 
2.4.4 Comet tracking  
GFP-EB3 stably transfected HeLa cells were imaged every 2’ with the 
spinning disk microscope. Individual comets were manually tracked using the 
“Manual Tracking” plugin of ImageJ. Comets were followed continuously until 
the fluorescent signal disappeared. Three parameters were extracted from the 
tracking: comet total speed, total distance and total time. The comet time is 
defined as the continuous time a single comet track is followed (in seconds). The 
comet distance is the distance the comet travelled until the signal disappeared 
(µm). The comet speed is defined by the formula v=mean distance (µm)/time (sec) 
and it represents the mean velocity a comet travels between consecutive time 
frames. 
 
2.4.5 Statistical analysis and data presentation 
In charts where data are represented as box-whisker plots, the box size 
represents 75% of the population and the line inside the box represents the median 
of the sample. Maximum (in the upper quartile) and the minimum (in the lower 
quartile) values are represented by the size of the bars (whiskers). A parametric 
one-way analysis of variance (ANOVA) was used to perform statistical analysis 
for multiple groups. These statistical analyses were performed using SigmaStat 3.5 
(Systat Software, Inc.). In the case that only two experimental groups were 
compared, parametric t test was used.  
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2.4.6 Micro-contact printing and cell patterning 
Micropatterned dishes were kindly provided by Matthieu Piel151. The 
micropatterned dishes used had parallel fibronectin lines (12µm wide) printed. 
Cells were trypsinized and resuspended in fresh medium at a density of 104 
cells/ml before seeding onto the micropatterned coverslips. After 30 min of 
seeding, HeLa cells had attached to fibronectin. Non-adherent cells and debris 
were removed by replacing the medium with fresh medium. 
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CHAPTER 3: IDENTIFICATION OF DLC2 AND 
DESCRIPTION OF DLC2 KNOCKDOWN 
PHENOTYPE 
3.1    IDENTIFICATION OF DLC2 IN AN CELL-CELL JUNCTION INTEGRITY 
SIRNA SCREENING 
The importance of small GTPase regulation for the maintenance of cell-cell 
junctions and epithelial tissue integrity has been investigated in the Matter and 
Balda laboratory since several years. To gain a genome-wide view of which small 
GTPase regulators and effectors are involved in cell-cell junction formation and 
maintenance, a functional siRNA screen was carried out. The screen comprised 
265 genes: these included 20 small GTPases, various small GTPases regulators and 
effectors as well as some actin regulatory and binding proteins54 (Zihni et al. and 
Karl Matter, unpublished data). One of the cellular systems chosen as 
experimental model was a Human Corneal Epithelial cell line, HCE cells. These 
cells are a good model to study junction formation and maintenance because they 
form functional epithelial junctions and express many of the major junctional and 
polarity markers.  
After the siRNA library transfection, all 265 genes were analysed by 
immunofluorescence and classified on the basis of their effect on markers of cell-
cell junctions: β-catenin for AJs and ZO1 for TJs. Moreover, giantin was used to 
monitor the distribution of the Golgi, and Hoechst dye for nuclei detection. 
Candidates were split in three categories based on phenotype: no, weak and 
strong effects. DLC2, a Cdc42 and RhoA GAP protein was identified as having a 
weak effect on cell-cell junctions. Despite the weak phenotype, DLC2 is an 
interesting candidate because it had been reported to act as a tumour suppressor 
in several types of cancers130,137. The mechanism underlying the tumour suppressor 
activity is not clear, but it has been suggested to function as a regulator of 
migration, which may affect metastasis formation.   
When I joined the lab, I repeated the experiment to confirm the phenotype 
observed in the screen. I transfected a pool of 4 different siRNAs, specific for 
different regions of the DLC2 mRNA. These siRNAs had also been used in the 
screen. I also deconvoluted this siRNA pool by transfecting each siRNA alone and 
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compared the resulting phenotypes with cells transfected with a non-targeting 
siRNA. This was done to rule out off target effects.  
By comparing non-targeting and DLC2 siRNA transfected HCE cells, I 
noticed that DLC2 depletion caused an effect on E-cadherin and β-catenin 
localisation: it perturbs the countinous staining along the cell membrane (Figure 
3.1). This is particularly evident for E-cadherin, whereas it is not so intuitive for β-
catenin. This is due to the fact these pictures were taken with an epifluorescent 
microscope, and I could not focus on the plane of the junctions to get a neat 
picture. In confocal pictures shown later (Figure 3.5), the phenotype is more 
evident. Nevertheless, this picture shows that depletion of DLC2 impairs the 
junctional barriers: in fact, DLC2 depleted cells have opened gaps with the 
neighbouring cells (see cells with red asterisks). This phenotype was particularly 
strong in mitotic cells, suggesting the DLC2 might be of functional importance 
during mitosis. Alongside the broken junctions, the DNA staining often revealed 
an atypical chromosome arrangement in what I thought it could have been 
metaphase. At this stage I cannot define it is a defect of late promethaphase, or 
metaphase yet, but I decided to quantify this aberrancy to see if there was a 
significant increase in comparison with the Control. I counted structure where I 
could detect a straight and main line of chromosomes embedded in a bipolar 
spindle structure, with chromsomes aligned outside, in a secondary like plate. 
Hence, DLC2 depletion may not only affect junction maintenance but also the 
distribution and alignment of chromosomes. I have not yet established a direct 
correlation between spindle phenotype and junction aberration. I think it would 
have been good quantifying the number of cells that showed both phenotypes in 
the same cells.  
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Figure 3.1 DLC2 KD affects cell-cell junctions  
HCE cells transfected with control or DLC2-specific siRNAs (pool of those, were stained with AJs 
marker E-cadherin (green) and β-catenin (red). Red asterisks are pointing to mitotic cells with 
broken junctions. 
Cells were fixed with methanol. Shown are epifluorescence microscopy images. 
White bar represents 20µm. 
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By counting mitotic cells showing an abnormal chromosome alignment, it 
was evident that the misalignment phenotype is consistent for DLC2 depletion as 
it was observed with all four individual siRNAs (Figure 3.2).   
 
 
 
Figure 3.2 DLC2 regulates metaphase plate alignment  
Independent transfection of 4 different DLC2 targeting siRNAs causes an increase of aberrant 
metaphase plates (red bars) and a decrease of normal ones (blue bars), compared with the control 
cells.  
     
 
When I validated the efficiency of DLC2 depletion by WB (Figure 3.3), I 
confirmed that both pool and individual siRNAs decreased DLC2 protein level. 
Since siRNA 4, despite of having trying to load several times an equal amount of 
lyasate (estimated by α-tubulin level), it fluctuated too much for α-tubulin level. 
showed a slight toxic effect on the cells (this was determined by looking at α-
tubulin levels when equal amounts of lysates were loaded), I decided to exclude it 
from the subsequent experiments and a new pool formed by oligo 1, 2 and 3 was 
established.     
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Figure 3.3 WB for validation of DLC2 KD in HCE cells 
WB for DLC2 expression in HCE cells: C control, P pool of four siRNAs, 1 siRNA 1, 2 siRNA 2, 3 
siRNA 3, 4 siRNA 4. α- tubulin was used as a loading control. 
 
 
Since the most evident junctional phenotype was in mitotic cells, I looked at 
the mitotic spindle structure in HCE cells, to see if I could detect abnormal 
structures. Figure 3.4 shows that depletion of DLC2 (pool or individual siRNAs) 
impaired the formation of mitotic spindles with a normal morphology, but does 
not alter the number of centrosomes. Pictures in Figure 3.4 are epifluorescence 
microscopy, but one can spot two centrosomes per cell. It would have been better 
having confocal pictures, for a finer and more precise description of this 
phenotype. In the same picture, as the α-tubulin staining revealed, microtubule 
fibres were no longer arranged in the typical diamond-shape structure seen in 
control cells. Hence, depletion of DLC2 seems to affect either spindle formation or 
maintenance.  
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Figure 3.4 DLC2 KD affects spindle morphology  
HCE cells transfected with control or individual siRNAs specific for DLC2 were stained with 
mitotic spindle markers: γ-tubulin (green) and α-tubulin (red).  
Cells were fixed with methanol. Shown are epifluorescence images. 
Bar represents 20µm. 
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3.2    FURTHER VALIDATION AND ANALYSIS OF DLC2 KD PHENOTYPE 
I next asked whether the junctional phenotype observed in the first sets of 
experiments was specific for the markers investigated or could also be observed 
with other types of junctional markers. Figure 3.5 shows that there was a strong 
effect on both occludin and ZO1 (Figure 3.5A) (TJ markers), and on E-cadherin/α-
catenin (Figure 3.5B) and p120Catenin (AJ markers). From these data, the 
junctional defect does not appear to be constrained to a particular subgroup of 
components of the junctional complex.  
As shown previously, the strongest effect appeared in mitotic cells (Figure 
3.6), where impairment of cell-cell junctions (represented by α-catenin staining) 
correlated with the appearance of aberrant mitotic spindle structures (α-tubulin 
staining). Quantification of misaligned metaphase chromosomes showed that 
depletion of the DLC2 KD significantly increased the number of cells with 
misaligned metaphase plates (Figure 3.7).  
By looking in detail at the mitotic spindle structure, it was also evident that 
MTs (α-tubulin and EB-1 -plus-ends marker of microtubules- staining) were 
affected. DLC2 depletion altered the structure of the mitotic spindle, with 
microtubules no longer trapped in the diamond-shape structure and 
chromosomes misplaced outside of the metaphase plate (Figure 3.8).   
Previous work demonstrated that p120catenin mediates the anchorage of 
astral microtubules at cell-cell junctions. Astral MTs are the microtubules 
nucleated at centrosomes that spread towards the cell cortex and are responsible 
for the positioning and orientation of the mitotic spindle throughout mitosis. In 
Figure 3.5, I have shown that p120catenin was mislocalized from the cell cortex 
region upon DLC2 depletion, indicating that the linkage between MTs and the cell 
cortex was impaired. Another key component in the MTs anchorage at the cell-cell 
junctions is APC. Figure 3.9 shows that DLC2 depletion affected dramatically APC 
localization and that the effect was equally strong on interphase cells and mitotic 
one: figure 3.9 shows indeed that the thick ring of APC at the cell cortex is widely 
reduced in DLC2 depleted cells, or completely abrogated. I observed previously 
that also p120catenin localization was heavily perturbed in both mitotic and 
interphase cells. This might imply that MTs attachment and therefore dynamics 
are impaired in interphase cells too.  
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Figure 3.5 DLC2 KD affects cell-cell junctions  
Control and DLC2 KD HCE cells stained with AJs markers E-cadherin red and β-catenin occludin 
(OCL) red and ZO1 green (A), AJs markers E-cadherin red and α-catenin (B), p120catenin red and 
α-catenin (C).  
Cells were fixed with methanol. Shown are confocal images. 
Bar represents 10µm. 
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Figure 3.6 DLC2 KD affects spindle stability 
This figure shows the effect on the mitotic spindle in HCE cells when DLC2 was depleted (α-
tubulin in green). These cells were stained with α-catenin in red.  Cells were fixed with methanol. 
Shown are confocal microscopy images. 
Bar represents 20µm. 
 
 
 
 
 
Figure 3.7 DLC2 regulates metaphase plate alignment  
Transfection of a pool of 3 DLC2 targeting siRNAs in HCE cells caused an increase of aberrant 
metaphase plates (red bars) and a decrease of normal ones (blue bars), compared with the control 
cells.  
Bars represent means of 3 independent experiments. Over 60 cells were counted per condition.  
* p<0.05. Error bars represents standard deviations. 
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Figure 3.8 DLC2 KD affects spindle architecture 
This figure shows the effect on the mitotic spindle in HCE cells when DLC2 was depleted (α-
tubulin in green). Cells were stained for EB1 (plus-end marker) in red. Cells were fixed with 4% 
PFA and methanol. Shown are confocal microscopy images. 
Bar represents 10µm. 
 
 
 
Figure 3.9 DLC2 KD affects localization of APC at cell-cell junctions 
Control and DLC2 depleted HCE cells were stained for APC in red and α-tubulin in green. Cells 
were fixed with methanol. Shown are confocal microscopy images. 
Bar represents 10µm. 
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3.3    DLC2 KD AFFECTS THE DE NOVO JUNCTION FORMATION AND THIS 
CORRELATES WITH CHROMOSOME MISALIGNMENT 
To test if there is a correlation between junction formation and chromosome 
misalignment in metaphase, I performed a calcium switch experiment. In this 
assay, cells are resuspended in low calcium media. The initial calcium depletion 
disrupts junctional complexes; by adding calcium back to the cells, junction 
formation is induced.  
Figure 3.10 shows control cells in low calcium also had misaligned 
metaphase plates at a percentage similar to DLC2 depleted cells in normal calcium 
medium (~40%). Upon adding calcium to the control cells, this number decreased 
gradually through time until the 24 hour time-point when junctions were perfectly 
formed. On the contrary, the percentage of DLC2 depleted cells with misaligned 
metaphase plates remained high (Figure 3.10C).  
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Figure 3.10 Spindle stability correlates with junction assembly 
(A) Examples of aligned and misaligned metaphase control HCE cells at time 0’ and aligned 
metaphase control cells 24 hours after calcium addition. (B) Examples of misaligned metaphase 
DLC2 KD HCE cells at time 0’ and 24 hours after calcium addition. In panels A and B, cells 
transfected with siRNAs were stained for DLC2 (red), α-tubulin (blue) and E-cadherin (green) after 
performing the calcium switch protocol. Shown are epifluorescence microscopy pictures. Bar 
represents 10µm. (C) Quantification of Calcium switch assay: control normal metaphase, first 
group of bars; control misaligned cells, second group of bars; DLC2 KD normal metaphase, third 
group of bars; DLC2 KD misaligned cells, fourth group of bars. Bar colour represents different time 
points after calcium addition: dark blue 0’; red 30’; green 90’; purple 4h; light blue 6h; orange 24h. 
Bars represent mean of values. Over 60 cells per conditions were counted. 
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3.4    CELLS OVEREXPRESSING DLC2 DO NOT ENTER CELL CYCLE  
To further confirm the DLC2 depletion phenotype specificity, I aimed to transfect 
DLC2 and non-targeting siRNAs into HCE cells and to rescue depletion with a mouse 
version of DLC2. The construct transfected well and could easily be detected; however, 
despite many transfected cells were detected, no transfected mitotic cells were found, 
indicating that DLC2 overexpressing cells may not proliferate. 
To rule out the possibility that the absence of transfected mitotic cells was due to a 
technical issue, I tried to optimize the conditions of transfection. Firstly, cells were 
transfected with mouse DLC2-HA and were then treated overnight with Nocodazole to 
promote synchronization of cells in prophase. The cells were then fixed and prepared for 
analysis. Once again, no transfected mitotic cells were detected (Figure 3.11).  
Next, I transfected cells with a form of DLC2 under a promoter responsive to the 
tetracycline repressor and co-transfected a plasmid encoding the tetracycline repressor. In 
these conditions, only the addition of tetracycline activates DLC2 expression. These 
allowed me to control precisely the moment the cells should have expressed transfected 
DLC2. Alongside the transfection, cells were treated with Nocodazole overnight, to 
increase the number of mitotic cells. Four hours before fixation, tetracycline was added to 
the cells to allow DLC2 expression. Despite DLC2 expression was induced in cells in 
mitosis, no transfected mitotic cells were found (Figure 3.11). 
There could have been other approaches I had not tried, that could have helped me 
in overexpressing DLC2 in mitotic cells. I could have titrated more the DLC2 cDNA 
concentration more, for instance, and also I cannot exclude the tag itself does not obstacle 
the right localization and expression of DLC2 construct.  
Overall, these data suggest that DLC2 overexpression inhibits the entry in mitosis 
and may even trigger the exit of cells from the cell cycle if overexpressed during the cell 
cycle.     
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Figure 3.11 Transfection of DLC2 cannot be used to demonstrate rescue 
HCE cells were treated with nocodazole ON and then transfected for 6h, or cotransfected with 
DLC2-HA and Tet-repressor constructed, synchronized ON and treated with tetracycline for 4h to 
induce DLC2 expression. The cells were then stained with Hoechst dye, HA to detect transfected 
DLC2 (in red) and α-tubulin in green. Note, in none of these cases mitotic cells overexpressing 
DLC2 were found. Shown are confocal microscopy pictures. 
Bar represents 10µm. 
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3.5    DISCUSSION 
Initially DLC2 was picked as a candidate in a cell-cell junction integrity 
screen. Here, I showed that DLC2 is important for epithelia in a dual manner: first, 
junctions are destabilized and this is particularly evident in mitotic cells. As I 
discussed in the introduction, it is paramount that a cell retains cell-cell junctions 
in mitosis since this guides cell division in the correct tissue plane, and it prevents 
cells from escaping the epithelial layer. On the other hand, mitotic cells showed 
aberrant mitotic spindle structures with scattered chromosomes and microtubules 
not tidily organized in the typical diamond-shape machinery.  
Interestingly junction stability and chromosome alignment need to be finely 
orchestrated to ensure correct cell division. The calcium-switch experiment 
demonstrated that when junctions are disassembled due to lack of calcium, the 
number of misaligned metaphase plates increased in control cells. This number 
decreased with the re-addition of calcium, indicating that junction stability is 
essential for chromosome alignment in metaphase. However, DLC2 depleted cells 
failed to rescue chromosome alignment after calcium re-addition, indicating that 
DLC2 is important for the regulation of chromosome alignment and junction 
stability in mitosis.  
I can speculate, so far, that DLC2 phenotype seems to be connected to a 
defect in astral MT anchorage. This is supported by the evidence that p120catenin 
and APC (mediators of MT anchorage at the cell cortex) are mislocalized from the 
cell cortex upon DLC2 depletion. It seemed to me that APC mislocalization is 
actually stronger than the one observed for p120catenin and is evident in 
interphase cells as well. This would need to be proved by quantifying the signal 
intensity. Nevertheless, the observed defect on APC and p120catenin raises the 
possibility that there might be an effect on MT anchorage at the cell cortex in 
interphase cells.  
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CHAPTER 4: DLC2 REGULATES CDC42 IN 
METAPHASE 
4.4   DLC2 IS A GAP FOR CDC42 AND RHOA 
In 2003, DLC2 was reported to have GTPase activating protein (GAP) 
activity for Cdc42 and RhoA, but not Rac104. When small GTPases were originally 
characterized, they were distinguished on the base of their effect on actin45. In 
particular, overactivation of RhoA was shown to induce formation of stress fibres. 
Since DLC2 was reported as a GAP for RhoA, firstly I confirmed this by checking 
if DLC2 depletion could cause an increase in stress fibre formation. Figure 4.1 
shows DLC2 depletion indeed led to increased stress fibre formation in interphase 
cells, suggesting that RhoA was more active. Primarily in mitotic cells, I also 
observed an increase in membrane spikes reminiscent of filopodia, suggesting that 
DLC2 depletion might also lead to increased levels of GTP-bound Cdc42. Pictures 
shown are projections of the whole z-stack. HCE cells in control situation barely 
forms stress fibres or filopodia. They are extremely flat and therefore I have 
decided to show and analyze the whole z-stack, rather than showing a single basal 
section.   
I next used a G-LISA assay to measure levels of activated small GTPases. By 
comparing control and DLC2 depleted HCE cells, it was evident that DLC2 
depletion induced an increase in GTP-bound RhoA and Cdc42, but not Rac 
(Figure 4.2 A).  
In the previous chapter, I had shown that the most dramatic phenotype of 
DLC2 KD appeared in metaphase. I therefore tested small GTPase activation levels 
upon DLC2 depletion in mitotic cells. In order to do this, I used a method 
validated and published previously. Kimura et al. had shown that after 
synchronization of cells in prometaphase with Nocodazole (Noc) treatment (100 
nM) followed by wash-off, it is possible to trigger synchronized entry into mitosis 
with a peak of metaphase/anaphase cells at 45 minutes, and telophase cells after 
90 minutes after release of the block141. Performing G-LISA assays at these time-
points and comparing with cells still arrested revealed that only GTP-bound 
Cdc42 was increased in metaphase cells upon depletion of DLC2 (Figure 4.2B and 
C).  
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This method had been changed for the original protocol adopted by 
Kimura et all. I am aware that the lack of initial block in S-phase and the lack of 
mitotic shake-off after nocodazole treatment might represent an issue since the 
rest of the cells in interphase will have an effect on the measurement. Taken this 
into account, it must be said that we can exclude the difference I see I metaphase 
upon DLC2 depletion has to be attributed to the interphase cell population. This is 
because if this was true, I most likely would have observed this change at the 
other time point too, since the percentage of non dividing cells is the same of that 
present at the 45’. Therefore, the lack of effect at the other time-point is an 
indication that Nocodazole treatment per se does not change the level of active 
RhoA or Cdc42 in HCE when DLC2 is depleted, compared with the control. This 
made me confident in further using this short version of the method also in other 
experiments I describe afterwards in this thesis. In any case, to be extremely sure it 
would have been interesting performing the same experiments, by increasing the 
pool of mitotic cells by collecting the prometaphases and then release them from 
the Nocodazole block (mitotic shake off). 
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Figure 4.1 DLC2 KD induces increases in actin stress fibres  
Control and DLC2 KD HCE cells stained with Hoechst and phalloidin. Note, DLC2 KD increased 
stress fibres along the base of cells and spikes along the lateral membrane. The picture are 
projections of the whole z-stack. 
Shown are confocal microscopy pictures. 
Bar represents 10µm. 
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Figure 4.2  DLC2 KD affects GTP-bound Cdc42 levels in mitosis 
(A) Cdc42, RhoA and Rac G-LISA assays were performed with non-synchronised cells. DLC2 KD 
resulted in an increase of active RhoA and Cdc42 but not Rac.  
(B) RhoA G-LISA of HCE cells treated with Nocodazole. Time points analysed: 0, 45, and 90 
minutes. At 45 minutes (metaphase peak), DLC2 depletion did not effect RhoA activity in mitosis. 
(C) Cdc42 GLISA of HCE cells treated with Nocodazole. Time points analysed: 0, 45, and 90 
minutes. At 45 minutes (metaphase peak), DLC2 depletion resulted in increased levels of GTP-
bound Cdc42. 
All bars represent means of values of three experiments. *<p0.05 ** p<0.01.  
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4.5 DLC2 DEPLETION-INDUCED CHROMOSOME MISALIGNMENT OCCURS 
VIA DEREGULATION OF CDC42 
The G-LISA experiments revealed DLC2 as a specific regulator of Cdc42 in 
metaphase. Considering that I observed a defect in chromosome alignment in 
metaphase, I speculated that misregulation of Cdc42 could be the primary cause 
for the chromosome misalignment defect detected in DLC2 depleted cells. 
However, at this point I could also not rule out a contribution of RhoA despite 
that I had seen no difference in levels of active RhoA, differential spatial 
regulation may not be evident in assays measuring total active GTPase levels. To 
establish more clearly which small GTPase was implicated in the observed 
chromosome misalignment phenotype, I performed a double knockdown with 
Cdc42/DLC2 or RhoA/DLC2 and counted the number of aligned and misaligned 
metaphase cells. As shown in Figure 4.3, only the simultaneous depletion of DLC2 
and Cdc42 resulted in a similar number of misaligned metaphase cells than 
control, indicating that co-transfection of Cdc42 siRNAs could rescue the DLC2 
phenotype. Figure 4.4 shows that DLC2 was equally well depleted in single and 
double siRNA transfections, indicating that rescue was indeed due to depletion of 
Cdc42.  
To further prove that RhoA was not involved the chromosome 
misalignment phenotype, I adopted a parallel strategy. I treated both control and 
DLC2 depleted HCE cells with C3 transferase (RhoA-C inhibitor). Although C3 
treatment inhibited RhoA activity – as indicated by the decrease in stress fibres 
induced by DLC2 depletion (Figure 4.5A) - it did not result in a decrease of cells 
with misaligned chromosomes (Figure 4.5B). Hence, the mitotic DLC2 phenotype 
cannot be rescued by RhoA inhibition.  
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Figure 4.3 Cdc42 but not RhoA is involved in the misalignment phenotype caused by DLC2 
depletion.  
HCE cells were transfected with Control, Cdc42, DLC2, Cdc42/DLC2 specific siRNA, or control, 
RhoA, DLC2 and RhoA/DLC2 siRNA. Cells were analyzed for metaphase plates misalignment 
defects. Panel A and B represent percentage of aligned metaphase plates (blue bars) and 
misaligned metaphase plates (red bars).   
All bars represent means of values of three experiments. *<p0.05 ** p<0.01.  
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Figure 4.4 WB of Cdc42/RhoA KD and transfection of Cdc42 constructs  
HCE cells were transfected with siRNAs as indicated. The cells were then lysed and expression of 
the indicated proteins determined by WB. 
α-tubulin was used as an internal loading control. 
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Figure 4.5 RhoA is not involved in the misalignment phenotype caused by DLC2 depletion.  
(A) Epifluorescence microscope pictures of actin staining in of Control and DLC2 siRNA 
transfected HCE cells that were treated with C3 transferase as indicated. Control cells did not have 
active stress fibres, but DLC2 depletion induced actin stress fibres and these were abolished upon 
C3 transferase treatment.  
(B) Count of misaligned/normal metaphase HCE cells upon transfection of Control (C) and DLC2 
siRNAs followed by treatments with C3 transferase as indicated. Values in the graph are an 
average of 2 experiments. 
Bar represents 10µm. 
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4.6 DLC2 LOCALIZES ALONG MTS  
I next stained cells for DLC2 to identify the subcellular localization of the 
protein. I used a commercially available antibody (see Material and methods) that 
recognised DLC2 specifically in immunoblots. As Figure 4.6 shows, the DLC2 
antibody labelled microtubules in interphase and metaphase cells. In metaphase, 
DLC2 decorated the mitotic spindle, suggesting that DLC2 associates with 
microtubules in interphase and mitotic spindle cells. Here, the pattern looks quite 
dotted suggesting that perhaps DLC2 does not decorate smoothly microtubules, 
but maybe parts of them where vescicles are attached. The two-hybrid screening 
results suggest that the nature of the interaction is direct, but nevertheless DLC2 
can localize in patches, resembling a vescicular localization. In mitosis, DLc2 
localises specifically along the MTs within the spindle. It is hard to detect it along 
the astral MTs, but I have seen DLC2 localizing with microtubules along the cell 
cortex (Fig 4.6 A). This suggests that despite astral MTs are usually less dense and 
bright, DLC2 is able to associate with other MTs, apart from those within the 
spindle. The microtubule staining was strongly reduced upon transfection of 
DLC2 siRNAs (Fig 4.6 B). Hence, DLC2 seems to interact, directly or indirectly, 
with microtubules.  
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Figure 4.6 DLC2 localizes on the mitotic spindle 
(A) HCE cells were stained for α-tubulin and DLC2 in red. Cells were fixed with 4% PFA and 
methanol. Shown are confocal images. 
(B) DLC2 staining disappears in HCE cells transfected with DLC2 specific siRNA, compared with 
control. 
Bar represents 10µm. 
 
 
 
Identifying interaction partners is fundamental for the identification of the 
molecular mechanism by which DLC2 regulates mitotic spindle organisation. By 
performing co-immunoprecipitation assays, I found that DLC2 interacts with α-
tubulin, EB-1 (a marker of the plus end of the MTs), and the AJ markers 
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p120catenin and E-cadherin (Fig. 4.7). TJs proteins were not found to co-
immunoprecipitate (Figure 4.7 right panel), and also β-catenin.  
I have performed this IPs not on cold, to prevent MTs from depolymerising, 
since from DLC2 staining I have never observed DLC2 dots associated with singe 
subunit of tubilin (e.g. in the proximity of tips of MTs next to cells cortex). This 
experimental procedur choice could interfere a little with the results because the 
lack of depolymerization might drive aspecific immuniprecifitation of MT 
interactors, such as motor proteins or scaffolds, which are not interacting or 
forming necessarily a complex with DLC2. Perhaps, to enforce the specificity of 
my assay I should have tried to test the presence of other interactors, such as GEF-
H1 which is unlikely to bind DLC2, or other molecules (dynein or CLASPs). 
Nevertheless, this experiment suggested that DLC2 might be involved in the 
regulation of the interaction between the plus end tips of MTs E-cadherin-based 
cell-cell contacts. 
 
 
 
 
Figure 4.7 Identification of candidate interaction partners  
Immunoprecipitates of DLC2 from HCE cell extracts were analyzed by WB against α-tubulin, EB1, 
E-cadherin and p120catenin (left panel) and OCL, ZO-1 and β-catenin (right panel).  
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4.7 DISCUSSION 
In this chapter I have shown that DLC2 is a functionally relevant GAP for 
both Cdc42 and RhoA in non-synchronised HCE cells, but only relevant for the 
maintenance of active Cdc42 levels during mitosis. Moreover, Cdc42 is the GTPase 
relevant for chromosome alignment downstream of DLC2. This was supported by 
the observation that double knockdown of DLC2 and Cdc42 is able to rescue the 
number of misaligned metaphase cells induced by single depletions of either 
Cdc42 or DLC2. Double depletion DLC2/RhoA or C3 transferase treatment failed 
to rescue the DLC2 KD phenotype, further supporting the functional specificity of 
Cdc42.  
During metaphase, chromosomes should be stably attached to kinetochore 
fibres and be aligned properly into a metaphase plate. I have not yet explained 
how DLC2 causes the observed chromosome defect, but the fact that endogenous 
DLC2 staining reveals a localization along the microtubules inside and outside the 
mitotic spindle supports the already mentioned idea that DLC2 regulates 
microtubules dynamics via regulation of Cdc42 levels in metaphase. Once again, I 
cannot rule out DLC2 plays a role in microtubule regulation outside mitosis. In 
contrast, G-LISA results show that DLC2 regulates level of active Cdc42 also in 
interphase cells; however, the roles of DLC2 in interphase might be more complex 
since at this stage also RhoA is regulated by DLC2. Moreover, if DLC2 also 
regulates microtubules in interphase cells, this function is not as important as 
during mitosis, as cell-cell adhesion is not as obviously affected in interphase as in 
mitotic cells.  
Nevertheless, the immunoprecipitation experiment re-enforces the idea that 
DLC2 is involved in anchorage and stabilization of microtubules in epithelial cells. 
DLC2 is able to form complexes with AJs components such as E-cadherin and 
p120catenin (the latest is directly connected to the plus ends of the microtubules 
via EB1) and also co-immunoprecipitates α-tubulin and EB1. 
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CHAPTER 5: KIF1B IS A KEY ELEMENT OF THE 
DLC2 PATHWAY   
5.1 Introduction to forces acting on the mitotic spindle 
The mitotic spindle is not a steady structure; on the contrary, it is highly 
dynamic and constantly under change. The typical diamond shape structure 
detectable in mitosis is the result of a complicated network of many and different 
types of microtubules organized in a unique and finely balanced manner.  There 
are three major categories of microtubules contributing to the mitotic spindle: 
kinetochore microtubules, responsible for chromosome attachment and alignment 
onto the metaphase plate; non-kinetochore fibres, fundamental for stabilization of 
chromosomes inside the spindle and their segregation during anaphase; and astral 
microtubules that anchor the mitotic spindle to the cell cortex. 
In 2009, Dumont and Mitchison reviewed forces acting on the mitotic 
spindle in mammalian cells152. They identified five major force-generating 
mechanisms: the first is based on kinesin-5 family members, which are motors 
cross-linking microtubules in the spindle that are responsible for pushing 
microtubules apart by outward force and are required for bipolarity in most 
spindles; the second involves microtubule depolymerisation at the kinetochores; 
the third is found at the poles and involves dynein and/or minus-end kinesins, 
which organize and focus minus-ends; the fourth involves chromosome arms and 
plus-end-directed chromokinesins, which push microtubules, exerting away-from-
the-pole force; the last mechanism is located at the cortex and involves dynein and 
kinesin 1 family members, which pull on astral MTs (Figure 5.1).  
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Figure 5.1 Forces acting on the mitotic spindle  
Cartoon representing forces acting on the mitotic spindle. Five different categories of forces can be 
identified: (1) the first is based on kinesin-5 family members, motors cross-linking microtubules in 
the spindle, responsible for pushing microtubules apart by outward force; (2) the second involves 
depolymerization at the kinetochores; (3) the third is found at the poles and is controlled by dynein 
and/or minus-end kinesins; (4) the fourth involves chromosome arms and plus-end-directed 
chromokinesins, which push microtubules, exerting away-from-the-pole force; (5) the last 
mechanisms is located at the cortex and involves dynein and kinesin 1 family members, which pull 
on astral MTs (adapted from Dumont and Mitchision, 2009)152. 
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5.2    DLC2 KD does not effect dynein but alters Kif1B localization 
Since DLC2 depletion resulted in increased misaligned metaphase plates 
and a distortion of the mitotic spindle itself, I raised the question of how forces 
acting on the mitotic spindle are altered upon DLC2 depletion.  
Four out of five classes of forces identified in the previous section are 
instigated by motors; therefore, I decided to test whether DLC2 depletion had an 
effect on kinesins or dyenin. Staining for dynein in control and depleted cells 
revealed that dynein localisation was not altered upon depletion of DLC2 (Fig 5.2). 
This suggests that DLC2 does not have an evident effect on dynein localization in 
the mitotic spindle. In fact, dynein staining simply reflected the distorted 
microtubules patterned caused by DLC2 depletion. Moreover, dynein is a motor 
protein that walks towards the minus end of the microtubules, and the defect 
observed in DLC2 depleted cells could be thought of as directly connected to the 
plus-ends. It is indeed the plus-ends of the microtubules that connect the mitotic 
spindle to the cell cortex on one hand, and, on the other hand, they are responsible 
for capturing chromosomes. This gave me reasons to believe that I should 
investigate kinesins, which are plus-end directed motor proteins.      
Interestingly, one of the first papers published on DLC2 showed a yeast 
two-hybrid screen in which they used DLC2 as a bite139. They found a member of 
the kinesin 3 family, Kif1B, to interact with DLC2. Interested in verifying if this 
kinesin was a part of the jigsaw I was trying to resolve, I first tested whether Kif1B 
interacts with DLC2 by co-immunoprecipitation. Indeed, the two proteins 
efficiently co-immunoprecipitated with each other, indicating that they also form a 
complex in epithelial cells (Figure 5.3).  
I next looked at Kif1B localization and asked if and how its localization was 
affected by DLC2 KD. Figure 5.4 illustrates that in control cells Kif1B localized at 
the cell cortex, suggesting it might be implicated in astral MT anchoring and 
pulling. Upon DLC2 depletion, Kif1B was dramatically decreased at the cell 
cortex, indicating that DLC2 is important for Kif1B localization. By WB, Kif1B 
protein levels were decreased upon DLC2 depletion, further supporting the 
importance of DLC2 for Kif1B (Figure 5.5). As Kif1B is a motor protein and my 
data show that it localises to the cell cortex, these observations are compatible with 
the hypothesis that depletion of DLC2 affects the balance of forces that act on the 
mitotic spindle.  
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Figure 5.2 Dynein is not affected by DLC2 depletion 
Control and DLC2 depleted cells were stained for α-Tubulin (green) and dynein in red. Cells fixed 
with 4% PFA and methanol. Shown are confocal microscopy images. 
Bar represents 10µm. 
 
 
 
 
Figure 5.3 Identification of DC2-Kif1B interaction  
Immunoprecipitates of DLC2 or Kif1B were analysed by WB with antibodies against the two 
proteins. 
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Figure 5.4 Cortical Kif1B is delocalized upon DLC2 depletion 
Control and DLC2 depleted cells were stained for α-tubulin (green) and Kif1B in green. Cells were 
fixed with methanol. Shown are confocal microscopy images. 
Bar represents 10µm. 
 
 
 
Figure 5.5 DLC2 depletion affects Kif1B protein levels 
WB for DLC2 and Kif1B in HCE cells transfected with control, DLC2 or Kif1B siRNAs. DLC2 
affects Kif1B total level. α-tubulin was used as a loading control. 
The two charts show quantification of Kif1B and DLC2 signal intensity as a protein/α-tubulin ratio 
normalized against the control ratio. This is the quantification of the blot shown in this picture. 
According to this picture, DLC2 depletion results in a 20% reduction of Kif1B protein level. It 
would be good to quantify other blots and estimate an average. A similar effect is also supported 
by the Figure  6.6. 
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5.3    What is known about Kif1B? 
Until this point, I did not know much about Kif1B and there is only limited 
information available in the literature. Kif1B was initially identified as mutated 
and functionally impaired in the neurological disease Marie-Charcot-Tooth153, and 
it was recently reported that mutations in Kif1B are associated with an increased 
risk of hepatocellular carcinoma154. Hepatocellular carcinoma is also the first type 
of tumour that had been linked to DLC2. As I described in the introduction, DLC2 
was reported to be frequently underrepresented in mRNAs isolated from 
hepatocellular carcinomas. Hence, Kif1B and DLC2 might be involved in the same 
pathway, and reduced expression of either protein might promote formation of 
hepatocellular carcinomas in a similar manner.   
Kif1B is a kinesin belonging to sub-family 3 of kinesins. It was reported to 
exist in two isoforms: KIF1Bα and KIF1Bβ, which are alternatively spliced 
products of the KIF1B gene located on 1p36.2. KIF1Bα is distinct from KIF1Bβ in 
the C-terminal cargo-binding domain; however, they have the same N-terminal 
motor domain155. Both isoforms were reported mutated in Marie-Charcot-Tooth 
disease and both were linked to hepatocellular carcinomas; however, only the 
longer one, beta, was reported to interact with DLC2 in the two hybrid analysis.  
Isoform β was also shown to direct transport of mitochondria156 and to 
regulate axonal transport of presynaptic regulator Rab3157. It still remains unclear 
how Kif1B is linked to the Marie-Charcot-Tooth disease or hepatocellular 
carcinoma.   
I am going to discuss further the role of Ki1Bβ in the next chapters, but I 
will always call it Kif1B for simplicity.  
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5.4    Depletion of Kif1B resembles DLC2 KD phenotype 
Since Kif1B localization was altered by DLC2 depletion, I wondered if 
Kif1B also played a role in mitosis. To investigate this, I first tested the specificity 
of three siRNAs against Kif1B (Sigma) and validated them by WB. Figure 5.6 
shows that individuals and a pool of the three siRNAs were able to reduce Kif1B 
protein levels. 
By staining for DLC2 in HCE cells depleted of Kif1B, it was evident that 
Kif1B did not affect DLC2 localization, despite that the mitotic spindle showed an 
aberrant shape. This suggested that Kif1B might play a role downstream DLC2, 
since its depletion did not have an effect on either DLC2 protein levels or 
localization (Figure 5.7).  
By staining for α-tubulin and E-cadherin, I observed that transfection of 
individual and pooled siRNAs resulted in fragmented junctions in mitotic cells 
and misaligned metaphase plates. The effect on junctions was not as strong as the 
DLC2 KD but mitotic spindles were affected in a similar manner (Figure 5.8). 
Quantification of aberrant metaphase cells revealed that Kif1B depletion induced a 
significant increase in the number of misaligned metaphases cells (Figure 5.9).     
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Figure 5.6 WB for validation of Kif1B KD 
WB for Kif1B expression in HCE cells transfected with siRNAs: C control, P pool of three siRNAs, 1 
siRNA 1, 2 siRNA 2, 3 siRNA 3. DLC2 is not altered upon depletion of Kif1B. α-Tub (α-tubulin) is 
used as internal control. 
 
 
 
Figure 5.7 Kif1B KD does not alter DLC2 localization 
HCE cells transfected with Kif1B specific siRNA pool were compared with control HCE cells 
transfected with a non-targeting siRNA. The cells were stained with DLC2 (red) and α-tubulin 
(green).  
Cells fixed with 4% PFA and methanol. Shown are confocal microscopy images. 
Bar represents 10µm. 
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Figure 5.8  Kif1B depletion phenocopies the DLC2 KD  
HCE cells transfected with individual siRNAs specific for Kif1B or a pool of those were compared 
to Control HCE cells transfected with a non-targeting siRNA and HCE cells transfected with a 
DLC2 siRNA pool. These cells were stained for the AJs marker E-cadherin (green) and α-tubulin 
(red).  
Cells were fixed with methanol. Shown are confocal microscopy images. 
Bar represents 10µm. 
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Figure 5.9 Kif1B regulates metaphase plate alignment 
Transfection of a pool of 3 Kif1B targeting siRNAs causes an increase of aberrant metaphase plates 
(red bars) and a decrease of normal ones (blue bars) compared with control cells. Over 60 cells per 
experiment were counted. Bars represent mean values of three experiments. * p<0.05 Error bars 
represent standard deviations.  
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5.5 Kif1B interacts with AJ components in a DLC2-dependent 
manner  
To determine whether Kif1B also forms complexes with cortical 
components, I performed a set of immunoprecipitations and looked at candidates 
I had previously identified to co-precipitate with DLC2 (components of AJs and α-
tubulin). Figure 5.10 shows that Kif1B antibodies co-immunoprecipitate 
p120catenin and E-cadherin, and α-tubulin. These results re-enforce the 
hypothesis that DLC2 and Kif1B act in the same pathway. TJ components (ZO-1 
and OCL) and β-catenin were not immunoprecipitated. 
At this point, I was interesting to know the role of Kif1B and DLC2 in 
complex formation. To answer this question, I performed immunoprecipitations of 
DLC2 upon depletion of Kif1B and looked at the co-immunoprecipitating 
protiens. I also performed an IP for Kif1B upon depletion of DLC2. Control 
immunoprecipitations were kept as a reference to study the effect of one or the 
other depletion (Figure 5.11). Interestingly, Kif1B was no longer able to interact 
with α-tubulin or AJs components upon DLC2 depletion. On the contrary, DLC2 
interactions were not affected by Kif1B depletion. Once again, this suggests a role 
for Kif1B more downstream of DLC2, and that formation of Kif1B complex with 
AJ components and α-tubulin are dependent on DLC2. Again, in none of the 
depleted conditions, TJ components (ZO-1 and OCL) and β-catenin were not 
immunoprecipitated. 
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Figure 5.10 Identification of candidate interaction partners  
Immunoprecipitates of Kif1B and DLC2 from HCE cell extracts were analysed by WB against α-
tubulin, E-cadherin and p120catenin, DLC2 and Kif1B.  
 
 
 
 
 
Figure 5.11 Identification of candidate interaction partners  
Immunoprecipitation of Kif1B and DLC2 in Control cells and in respectively DLC2 KD and Kif1B 
KD cells. WB against α-tubulin and E-cadherin. DLC2 and Kif1B. 
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5.6    Kif1B KD stimulates higher levels of active Cdc42  
To better understand the correlation between Kif1B and DLC2 I decided to 
look at active Cdc42 levels upon Kif1B depletion. Although this kinesin does not 
have GAP or GEF activity, it might contribute to Cdc42 regulation via its 
interaction partner DLC2. G-LISA performed on HCE cells showed that Kif1B 
depleted cells had higher levels of active Cdc42 in nonsynchronised cells (Figure 
5.12A), suggesting that Kif1B is indeed important for DLC2 function. Upon 
synchronized entry into mitosis, Kif1B depletion again led to increased Cdc42-
GTP levels after 45’ of Nocodazole washout, corresponding increased Cdc42 
activity in metaphase as I had observed for DLC2 depleted cells (Figure 5.12B). 
Hence, Kif1B is also required for normal control of Cdc42, suggesting that it might 
exert a regulatory role on DLC2. However, I cannot rule out a contribution by 
another Cdc42 regulator at this time.   
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Figure 5.12  Kif1B KD leads to increased active Cdc42 levels  
(A) Cdc42 G-LISA assay. Kif1B KD results in an increased Cdc42 activity.  
(B) Cdc42 G-LISA of HCE cells treated with Nocodazole. Timepoints analyzed: 0’, 45 minutes, and 
90 minutes. At 45 minutes (metaphase peak) Kif1B depletion results in an increased level of Cdc42. 
Bars represent mean values of three experiments. * p<0.05 Error bars represent standard 
deviations. The chart is an average of three experiments. 
 
 
Since DLC2 depletion induced increased levels of Cdc42 activity and in this 
condition Kif1B localization was dramatically perturbed, I wondered if Kif1B 
localization is regulated by active Cdc42 levels. To tackle this question, I expressed 
CA (Q61L) and DN (T17N) constructs of Cdc42 in control or DLC2 depleted cells. 
Figure 5.13 shows that overexpressing a DN form of Cdc42 in DLC2 KD cells 
restored Kif1B localization at the cell cortex. On the contrary, overexpression of 
CA in control cells led to mislocalization of Kif1B. This highlights the possibility 
that Kif1B localisation is regulated by Cdc42 activity. 
Double depletion Cdc42 and DLC2 restored Kif1B at the cell cortex further 
supporting the model that DLC2-regulated Cdc42 activity is important for Kif1B 
function. 
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Figure 5.13 Kif1B is at the cell cortex when Cdc42 is inactive  
Control and DLC2 KD HCE cells, untransfected or transfected with CA or DN Cdc42 were stained 
for Kif1B (in red), c-Myc (in green) and with Hoechst. The picture shows that Kif1B is mislocalized 
upon DLC2 KD, but if DN Cdc42 is overexpressed, Kif1B sits at the cell cortex, indicating Kif1B 
localization depends on Cdc42 activity.   
Bar represents 10µm. 
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Figure 5.14 Kif1B is recruited at the cell cortex when Cdc42 is not active. 
(Top panel) Confocal pictures showing Control, Cdc42 KD and DLC2 KD and Cdc42/DLC2 KD 
HCE cells stained in the left panel for Hoechst, Kif1B (red) red and α-tubulin (green).  Bar 
represents 10µm  
(Bottom panel) Quantification of Kif1B signal at the cell membrane from over 10 cells each 
condition.  
*** p<0.001 ** p<0.01  
 106 
5.7  Does Kif1B associate with kinetochores? 
Plus-end tips of microtubules are attached at the cell cortex on one end, and 
at the DNA via the kinetochores on the other side.  Since in both cases plus ends of 
microtubules are involved in anchoring other components to the spindle, and 
since I observed that Kif1B localized at the cell cortex but also that Kif1B depletion 
affected chromosome alignment, I wondered if Kif1B could be localized at the plus 
ends of the kinetochores. Hence, I co-stained cells for Kif1B and the kinetochore 
marker CREST. Figure 5.15 shows that I could indeed observe some Kif1B dots 
colocalizing with CREST. These dots were visible in both prometapahse and 
metaphase, suggesting that Kif1B might localize at the kinetochores during both 
capture and stabilization of chromosome attachment. To test if these dots were 
Kif1B specific, I knocked down Kif1B and observed that these dots disappeared 
(Figure 5.15). However, Kif1B also localizes to mitochondria; hence, there is a 
considerable amount of cytoplasmic, dotty staining. It is therefore difficult to be 
certain at this time that the Kif1B dots co-localizing with CREST is indeed due to 
kinetochore staining. Nevertheless, mitochondria are excluded from the 
metaphase plates, suggesting that an overlap with the mitochondrial staining is 
unlikely. Thus, I recognize the evidences for this type of association are little. It 
would have been helpful trying to use a vector with an appropriate tag to stain in 
fix cells (perhaps without the portion responsible for localization to mitochondria, 
which is not known in literature yet, since both the isoforms annotated in 
literature do localise at the mitochondria156). If this information was available, I 
could have expressed the rest of the protein and trying to see if the other domains 
are responsible for a localization of Kif1B at the kinetochores. Perhaps, it would 
have been also interesting performing some live imaging with this construct, to 
follow up the localization throughout mitosis.  
Since I had found that Kif1B recruitment to the cortex occurs when Cdc42 
activity is low, I depleted Cdc42 and looked at Kif1B localization. Depletion of 
Cdc42 emulates an inactive state, and in these conditions it seems to me that I 
could detect several Kif1B dots co-localizing with kinetochores (Figure 5.16). It 
seemed to me that depletion of Cdc42 was sufficient to restore Kif1B localization 
at the cell kinetochores upon double knockdown Cdc42 and DLC2. Unfortunately, 
to make the data stronger, I should have stained for a kinetochore marker 
alongside Kif1B. These data might indicate that Kif1B might indeed localize to the 
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kinetochores and that this association is regulated in the same way by Cdc42 
activity as association with the cell cortex.  
  
 
 
Figure 5.15 Co-localisation of Kif1B with the kinetochore marker CREST 
Control and DLC2 KD HCE cells were stained for CREST (kinetochore marker) and Kif1B (red). A 
single plane or a z-projection of metaphase and prometaphase cells were analyzed for both control 
and DLC2 KD cells. 
Cells were fixed with PFA 4% and methanol. Shown are confocal images. 
Bar represents 1µm. 
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Figure 5.16 Kif1B is recruited when Cdc42 is not active. 
Confocal pictures showing Control, Cdc42 KD and DLC2 KD and Cdc42/DLC2 KD HCE cells 
stained in the left panel for Hoechst, Kif1B (red) red and a-tubulin (green).  
Bar represents 5µm. 
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5.8   DISCUSSION 
I presented data in this chapter that indicate that Kif1B is an important 
DLC2 interactor and component of the DLC2 pathway. In 2004, the interaction 
between Kif1B and DLC2 was reported in a two-hybrid screen139. Here, I 
confirmed the interaction between the endogenous proteins extracted from HCE 
cells. Moreover, DLC2 plays a paramount role in controlling Kif1B localization at 
the cell cortex and its protein levels. On the contrary, DLC2 localization and 
expression were not influenced by depletion of Kif1B, suggesting that Kif1B might 
be in a more downstream position in the same pathway. Nevertheless, depletion 
of Kif1B led to increased Cdc42 activity, suggesting that the kinesis might also 
play a role in DLC2 regulation. However, I cannot exclude that this effect on 
Cdc42 involves another mechanism of Cdc42 regulation, such as another regulator 
or an indirect effect due to a feedback signal since the DLC2 pathway is disrupted.  
Depletion of Kif1B phenocopies DLC2 chromosome misalignment, indicating that 
regulation of Kif1B by DLC2/Cdc42 is important for mitosis. How Kif1B 
participates in regulation of the mitotic apparatus is not clear yet. I can imagine 
that Kif1B at the cell cortex mediates anchorage of microtubules by docking them 
at cell-cell junctions. This idea is supported by the co-immunoprecipitation of E-
cadherin, p120catenin and α-tubulin with Kif1B.  Upon perturbation of DLC2, 
Kif1B is misplaced and cannot associate anymore with the astral microtubules at 
the junctions.  Since this happens at the plus ends, it is possible that a similar 
mechanism regulates Kif1B association with the plus ends at the kinetchores of K-
fibers. Staining for Kif1B and CREST (kinetochore marker) revealed that Kif1B also 
might associate with kinetochores. Perhaps here too Kif1B regulates microtubules 
attachment. This would explain the effect of Kif1B on chromosome alignment. 
However it could also be that the chromosome defect is due to a defect of MT 
attachment at the cell cortex that is somehow sensed by the kinetochores. 
Noteworthy is the fact that Kif1B seems to ‘sense’ the active level of Cdc42 
within the cell. Presence of too high levels of active Cdc42 is sufficient to misplace 
Kif1B from the cell cortex. Hence, DLC2 depletion led to a loss of cortical Kif1B 
and this could be corrected by inactive Cdc42 or Cdc42 depletion. This 
active/inactive Cdc42 sensing strongly links Kif1B to DLC2. However, Kif1B does 
not simply act as sensor, since its depletion is sufficient to change active Cdc42 
levels. It seems then that the mechanism is not a one-way cascade, but rather a 
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complicated network with Kif1B influencing DLC2/Cdc42 activation and DLC2 
regulating Kif1B localization.      
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CHAPTER 6: DLC2 AND KIF1B DEPLETED CELLS 
SHOWS DELAYS IN METAPHASE 
6.1 DLC2 and Kif1B depletion does not affect spindle orientation 
Several reports in literature show that Cdc42 and its regulators are involved 
in the regulation of mitotic spindle orientation158–161. As I discussed largely in the 
introduction, mitotic spindle orientation is essential to determine where the cell is 
going to remain in the same layer. This influences the fate of a cell. Therefore, 
spindle orientation needs to be tightly controlled.  
When I started this project and I observed a mitotic phenotype in DLC2 KD 
cells, I thought that since Cdc42 is misregulated within these cells, the 
chromosome misalignment could have been due to a spindle misorientation with 
a consequent failure of the spindle.  To test this hypothesis, I compared Control, 
DLC2 KD and Kif1B KD HCE cells stained for E-cadherin, to determine the 
junction position, and γ-tubulin, to monitor the plane of the mitotic spindle. I then 
measured the angle between the line passing through the centrosomes and a line 
perpendicular to the substrate.  As Figure 6.1 shows, DLC2 KD and Kif1B KD cells 
did not show any increase in cells with misaligned spindles. Hence, the 
DLC2/Kif1B pathway does not regulate spindle orientation. 
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Figure 6.1 DLC2 and Kif1B depletion does not alter the spindle orientation  
Control (blue bars), DLC2 KD (red bars) and Kif1B KD (green bars) HCE cells were stained for γ-
tubulin in red and Ε−cadherin in green. A z-line was acquired and lines were drawn passing 
through the two spindle poles and the cell junctions. Spindle angles were calculated in the z-line 
picture by measuring the angle between a line perpendicular to the substrate and the line passing 
through the two spindle poles. 5 groups of angles were counted. Control, DLC2 KD and Kif1B KD 
cells spread among the 5 categories in a similar way. Bars represent mean values of 3 experiments. 
Over 30 angles per condition were counted.  
Cells were fixed with methanol. Shown are confocal microscopy images. White bars represent 
10µm. 
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6.2 DLC2 and Kif1B depleted cells show delays in metaphase 
To better understand DLC2 phenotype and identify at which step of mitosis 
the defect is initiated, I decided to use live cell. For this purpose, HeLa cells stably 
transfected with α-tubulin and H2B (DNA marker) were imaged on a spinning 
disc confocal microscope and followed from the beginning of mitosis 
(prometapahse) to the end of it (cytokinesis). Using the structure of the mitotic 
spindle as a reference, I calculated the length of prometaphase/metaphase 
(defined as the time from the nuclear envelop break-down to the appearance of 
the metaphase plate) and metaphase/anaphase (from the onset of the metaphase 
plate to chromosome segregation).  
Figure 6.2 A shows time-courses of three example cells. Comparing the 
times required by control cells with DLC2 and Kif1B KD cells, it became clear that 
there were differences in metaphase. Control cells segregated chromosomes after 
an average of 40 minutes from the entry into mitosis; DLC2 and Kif1B depleted 
cells showed delays in metaphase, with spindles not getting misorientated, but 
enhanced shaking, spinning in the same plane, and rocking from left to right 
(Watch Videos Chapter6-Control-atub-h2b, Chapter6-DLC2kd-atub-h2b, 
Chapter6-Kif1Bkd-atub-h2b). 
By measuring the length of prometaphase and metaphase, it resulted that 
DLC2 KD and Kif1B KD cells did not show any primary chromosome alignment 
defect, but the spindle did not become stabilised and underwent increased 
dynamic movements, resulting in prolonged times in metaphase and leading to 
chromosome misalignments. The times in metaphase were indeed almost the 
double for KD cells than for control cells (Figure 6.2 B).  Unfortunatelly, I have not 
shown a Kif1B KD cell starting from NEB but from already metaphase, since this 
cell had the most striking defect of misaligned metaphase plate, but it was found 
already in metaphase, when the movie was started.   
Similar results were obtained with fixed HCE cells. By treating HCE cells 
with Nocodazole as I have shown in Chapter 5 (see Materials and Methods for 
further information), it is possible to synchronize cells in different phases of 
mitosis. Keeping in mind that 0’ from the wash out corresponds to a peak of 
prometaphase, 45’ of metaphase/anaphase, and 90’ telophase, I compared the 
percentage of cells in specific phases in the different timepoints, in Control, DLC2 
KD and Kif1B KD cells. Figure 6.3 shows that at 90’ from the washout, the majority 
of control cells had reached telophase, DLC2 and Kif1B depleted cells were still in 
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metaphase. These results are thus in agreement with the live imaging experiments 
performed with HeLa cells.   
 
 
 
Figure 6.2 Live imaging of DLC2 KD and Kif1B KD HeLa cells 
(A) HeLa cells stably transfected with H2B-mCherry and α-tubulin-GFP and transfected with 
control, DLC2 or Kif1B siRNAs, were filmed throughout mitosis. Pictures have been taken with a 
Spinning Disc confocal microscope every 2 minutes. Watch Videos Chapter6-Control-atub-h2b, 
Video Chapter6-DLC2kd-atub-h2b, Video Chapter6-Kif1Bkd-atub-h2b. 
(B) Length of prometaphase and metaphase was calculated and plotted in a graph. * p<0.05.  
In charts where data are represented as box-whisker plots, the box size represents 75% of the 
population and the line inside the box represents the median of the sample. Over 30 cells were 
analyzed per condition. Maximum (in the upper quartile) and the minimum (in the lower quartile) 
values are represented by the size of the bars (whiskers).  
Scale bars are 10µm. 
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Figure 6.3 Mitotic index analysis reveals DLC2 and Kif1B depleted cells have a delay in 
metaphase 
Control (blue), DLC2 KD (red) and Kif1B KD (green) cells were counted to determine what it is the 
percentage of the different phases of mitosis among the whole popultion of mitotic cells. Cells were 
treated with Nocodazole and the following timepoints from the washing-off were analyzed: 0’, 45’, 
90’. 
The chart shows that depletion of DLC2 and Kif1B results in an increase of cells delayed in 
metaphase.    
Bars represent mean values of three experiments. * p<0.05 ** p<0.01 Error bars represent standard 
deviations. 
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6.3 The metaphase delay is checkpoint dependent 
As I discussed in the introduction, the purpose of mitosis is to equally 
segregate the duplicated chromosomes between two daughter cells. This task is 
accomplished by the mitotic spindle and the microtubules within that capture all 
the chromosomes, align them on a metaphase plate and then split them.  To 
ensure that each daughter cell inherits an identical copy of the genome, a cell has a 
checkpoint system that is ON to prevent anaphase onset until all the chromosomes 
are perfectly aligned and anchored. When the checkpoint is satisfied, anaphase 
can occur.  
One of the key elements of the checkpoint is Aurora B, a sensor molecule 
and kinase that phosphorylates targets downstream when chromosomes are not 
attached properly162–164. Aurora B requires phosphorylation of Ser311 by 
checkpoint kinase 1 (Chk1) (kinase best known for its role in the DNA damage 
checkpoint). Aurora B is activated by binding to inner centromere proteins such as 
INCEP, which triggers the phosphorylation of its own kinase domain. Binding to 
INCEP generates a gradient of phospho Aurora B localized in metaphase at the 
kinetochores, and in the middle of the spindle in anaphase 
Since DLC2 and Kif1B KD cells showed delays in metaphase, I checked if 
this was checkpoint dependent or not. I first looked at the global level of phospho-
Aurora B in control, DLC2 KD and Kif1B KD cells, untreated and synchronized. 
As shown in Figure 6.4, whereas control cells at the 90’ of the nocodazole washout 
showed little phospho-Aurora B, DLC2 KD and Kif1B cells still retained high 
levels of phospho-Aurora B, suggesting that the checkpoint was still on in the 
delayed metaphase cells. 
To further prove that the checkpoint was active, I decided to look at a 
substrate of Aurora B, Dsn1. P100 is an antibody raised against the Dsn1 
phosphorylation site at Ser100, when phosphorylated by Aurora B (gift by Iain 
Cheeseman). Figure 6.5A shows that upon depletion of DLC2 and Kif1B, HCE 
cells had high levels of phospho-Dsn1, indicating high levels of activate Aurora B. 
This was further supported by a quantification of the signal intensity (Figure 6.5 
B). These data reinforced the model that in DLC2 and Kif1B depleted cells the 
checkpoint was maintained active for longer than in control cells. 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Figure 6.4 DLC2 and Kif1B KD cells retain high levels of phospho Aurora B at the 90’ time point 
after nocodazole washout. 
Control, DLC2 and Kif1B KD HCE cells, treated or untreated with nocodazole, were lysed and 
analysed by WB as indicated.  
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Figure 6.5 DLC2 and Kif1B KD cells retained high levels of phospho-Dsn1 
(A) Confocal microscopy pictures showing Control, DLC2 KD and Kif1B KD HCE cells stained for 
Hoechst, p100 (phospho Dsn1 in red) and CREST (kinetochore marker in green). 
(B) Chart representing a typical experiment. Integrated intensities were scattered on the chart. The 
threshold (black line) was identified as the highest integrated intensity in control cells. Above the 
values are percentages of how many counted kinetochores show higher density.  
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6.4 Checkpoint remains active because of unattached kinetochores  
The Aurora B checkpoint senses unattached kinetochores. Therefore, I 
wondered if in the case of DLC2 and Kif1B depletion, the checkpoint was kept on 
longer because of unattached kinetochores. The most common way to check this is 
by taking advantage of a protein that sits at the kinetochores when kinetochores 
are not coupled to MTs: Mad2165–170.  
By staining with a commercial Mad2 Ab, and by quantifying the number of 
Mad2 dots detected within a cell, I observed that DLC2 and Kif1B depleted cells 
showed increased numbers of Mad2 positive dots (Figure 6.6). This suggested that 
in these cells kinetochores were not properly attached.  
I confirmed this result by using a live imaging approach with HeLa cells 
stably expressing Mad2-GFP. As Figure 6.7 and Figure 6.8 A show, DLC2 and 
Kif1B depleted HeLa cells showed longer in metaphase and with positive Mad2 
spots through-out the whole length of metaphase (watch Videos Chapter6-
Control-mad2, Chapter6-DLC2kd-mad2, Chapter6-Kif1Bkd-mad2). When the last 
dot had disappeared, anaphase finally occured. This experiment suggested that 
DLC2 and Kif1B depleted cells had defects in attaching or keeping attached all 
chromosomes to MTs. 
To determine the checkpoint dependence directly, I used an MPS-1 
inhibitor. MPS-1 is involved in the correct recruitment of the Mad1-Mad2 core to 
kinetochores when they are unoccupied170,171.  MPS-1 inhibitor treatment of DLC2 
KD and Kif1B KD HeLa cells rescued the prolonged metaphase times (Figure 6.8 
B), confirming that the delayed metaphase was due to prolonged activation of the 
checkpoint. 
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Figure 6.6 DLC2 and Kif1B KD cells retain increased numbers of Mad2 positive kinetochores 
(A) Mad2 staining for Control, DLC2 KD and Kif1B KD cells. Bar represents 5µm. 
(B) Chart representing the percentage of cells showing a specific number of Mad2-positive dots at 
the kinetochores. DLC2 and Kif1B KD cells show higher percentages of cells with more than one 
Mad2-positive dot. Over 50 kinetochores per condition were counted. 
Bars represent mean values. * p<0.05 *** p<0.001 Error bars represent standard deviations.
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Figure 6.7 Live imaging of DLC2 KD and Kif1B KD HeLa cells Mad2-GFP 
HeLa cells stably expressing Mad2-GFP and transfected with control, DLC2 or Kif1B siRNAs were 
filmed during mitosis. Pictures were taken with a spinning disc confocal microscope every minute. 
Watch Videos Chapter6-Control-mad2, Chapter6-DLC2kd-mad2, Chapter6-Kif1Bkd-mad2. 
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Figure 6.8 DLC2 and Kif1B KD cells retain GFP-Mad2 positive kinetochores for longer 
Top chart show the average of minutes cells retain GFP-Mad2-positive dots at the kinetochores. 
DLC2 and Kif1B KD cells show GFP-Mad2 dots for longer. 
Bottom chart show that the longer GFP-Mad2 staining is abolished if cells were treated with MPS-1 
inhibitor that blocks the mitotic checkpoint. Over 30 cells per condition were counted. 
In charts where data are represented as box-whisker plots, the box size represents 75% of the 
population and the line inside the box represents the median of the sample. Maximum (in the 
upper quartile) and the minimum (in the lower quartile) values are represented by the size of the 
bars (whiskers). * p<0.05. 
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6.5 DISCUSSION 
In this chapter, I have shown that the DLC2 spindle defect is not related to 
the previously reported Cdc42-regulated spindle orientation. On the contrary, 
cells depleted of DLC2 assemble spindles that have normally orientated spindles. 
However, these spindle seem have lost their anchorage and they spin inside the 
cells and shift from left to right throughout metaphase.  
I am aware that some of the experiments (live imaging) was done in HeLa 
cells, and others (mitotic index experiment) in HCE cells. HeLa cells are a model 
system really different from HCE cells and most importantly do not form any 
junctions, but I can compare the results on the cell division timing. Interestingly, 
in both the same line, DLC2 and Kif1B KD slows down metaphase, and moreover, 
throughout the long spinning and rocking movements, HeLa cells reveal that 
depletion of either DLC2 or Kif1B results in chromosome misaligned, such as 
those observed in HCE cells at the beginning of the project. It would have been 
important to validate the rocking movements in the HCE cell monolayer in live.   
The observed delays in metaphase are connected to the fact that DLC2 KD 
cells do not have chromosomes attached properly. This is sensed by Aurora B and 
reflected in prolonged activation of the checkpoint. Since some kinetochores are 
misattached, Mad2 is constantly recruited and only eventually it switches off and 
cells complete mitosis. At this stage I cannot say whether this affects chromosome 
segregation. However, I can imagine it is more likely that, strained by the long 
metaphase, the checkpoint eventually turns off and chromosomes are distributed 
unevenly between the two daughter cells. This has previously been described as 
chromosome fatigue.172 In this condition, cells adopt the strategy of exiting mitosis 
despite of the checkpoint and kinetochores remain misattachment in order to 
ensure cell survival, although the new cells will be aneuploid.  Aneuploidy is one 
of the possible ways cancer is triggered, as the excess or lack of DNA information 
can instruct a cell to a wrong behaviour, which can degenerate to cancer173,174.  
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CHAPTER 7: MDIA3, AN EFFECTOR OF CDC42 IN 
THE DLC2 PATHWAY 
7.1 On the quest of a Cdc42 effector 
When small GTPases are active, they transmit signals by binding directly 
their effectors. Through specific binding to a particular effector, small GTPases are 
able to initiate specific signalling cascades44,175. DLC2 depletion resulted in 
increased levels of Cdc42, suggesting that a Cdc42 effector was kept activated and 
contributed to spindle deregulation. Therefore, I was interested in identifying next 
the responsible Cdc42 effector. 
There are about 20 effectors reported for Cdc4244,176. Among all the known 
effectors, mDia3 was the one fitting best the criteria required to explain the mitotic 
phenotype. mDia3 is a still poorly characterized formin that is known to bind 
Cdc42. In 2004, Yasuda et al. showed that mDia3 and Cdc42 regulate chromosome 
alignment in HeLa cells96. Moreover, in the same paper endogenous mDia3 is 
reported to localize at the kinetochores.  
A few years later, Mao’s group presented mDia3 as a new target of Aurora 
B kinase94: mDia3 phosphorylation via Aurora B controls mDia3 activity and 
promotes formation of correct metaphase plates. These results led me thinking 
that mDia3 could be the effector I was looking for. 
To test this hypothesis, I firstly blotted lysates from control, DLC2 and 
Kif1B KD HCE cells, non-synchronized or synchronized, for mDia3 expression. I 
observed that mDia3 expression was higher in non-dividing cells (non treated 
cells) and at the 90’ in cells that had been depleted of either DLC2 or Kif1B. At 90’, 
most of the control cells had completed metaphase whereas DLC2 and Kif1B KD 
cells were delayed, and at this time point the levels of mDia3 were still as high in 
depleted cells as those in controls after 45’ (Figure 7.1). 
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Figure 7.1 DLC2 and Kif1B KD leads to high levels of mDia3 in interphase and after 90’ of 
nocodazole washout. 
Control, DLC2 and Kif1B KD HCE cells, treated or untreated with nocodazole, were analysed by 
WB as indicated. Expression of DLC2, Kif1B and mDia3 was detected. GADPH was used as an 
internal control.  
 
 
 
By staining for endogenous mDia3 in HCE cells, I noticed that mDia3 was 
diffusely cytosolic under control conditions, but DLC2 of Kif1B depletion 
stimulated mDia3 recruitment to the cell cortex (Figure 7.2 A). These data suggest 
that increased Cdc42 signalling promotes cortical recruitment of mDia3. In reality, 
to further support this evidence I should have used a marker of cell-cell junctions 
or cell cortex to define that mDia3 is enriched specifically at the cell cortex. 
Perhaps also α-tubulin would have been important in this experiment, to show 
that mDia3 upon depletion of DLC2 and Kif1B is over recruited at the plus ends 
towards the ell cortex.    
The mDia3 staining in DLC2 depleted cells was very similar to the one of 
Kif1B in control HCE cells. For this reason, I decided to check if mDia3, as Kif1B, 
could have been positioned at the kinetochores too. By staining for CREST, I was 
able to identify kinetochores in HCE cells. Figure 7.2 B shows that in control cells, 
no dots corresponding to kinetochores were detectable. However, mDia3-positive 
dots co-localazing with CREST were seen upon DLC2 and Kif1B depletion. Once 
again, I have to underline here the fact that this kinetochore staining is not 
sufficiently clear, and it would be nicer to use a mDia3 construct tagged of fused 
to a fluorescent protein, to monitor in live if it could localize at the kinetochores 
during cell division. 
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Figure 7.2 DLC2 and Kif1B KD cells have increased levels of mDia3 at the cell cortex and 
kinetochores. 
(A) Confocal pictures showing mDia3 stained in Control, DLC2 KD and Kif1B KD HCE cells. (B) 
Chart showing the quantification for mDia3 intensity at the cell cortex. n=8 Bars represent mean of 
values. *** p<0.001  
(C) Confocal pictures showing Control, DLC2 KD and Kif1B KD HCE cells stained for Hoechst 
(blue), CREST (green) and mDia3 (red). Bar represents 10µm (left panel) and 2µm (right panel). 
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7.2 mDia3 is recruited upon Cdc42 activation 
To further investigate mDia3 recruitment, I tried to alter active/inactive 
Cdc42 levels within the cell and monitored the effect on mDia3 localization. Upon 
depletion of endogenous Cdc42, no mDia3 was detected either at the cell cortex or 
at the kinetochores (Figure 7.3 A and B). Moreover, depletion of Cdc42 blocked 
mDia3 recruitment triggered by DLC2 depletion (Figure 7.2 A and B). Similarly, 
transfection of DN Cdc42 in DLC2 KD cells (Figure 7.4) prevented recruitment, 
and overexpression of CA Cdc42 in control cells was sufficient to induce mDia3 
recruitment to the cell cortex (Figure 7.4). As mentioned above, I should have used 
precise marker of cell cortex or kinetochores to define the enrichment or simply 
the staining localization of mDia3.  
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Figure 7.3 mDia3 is not recruited to kinetochores and cell cortex if Cdc42 is not active. 
Confocal pictures showing Control, Cdc42 and DLC2 KD and Cdc42/DLC2 KD HCE cells stained 
in A for Hoechst and mDia3, and in B for mDia3 (red) red and α-tubulin (green) in B. 
Bar represents 10µm (left panel) and 5µm (right panel). 
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Figure 7.4 mDia3 is at the cell cortex when Cdc42 is active  
Control and DLC2 KD HCE cells, untransfected or transfected with CA and DN form of Cdc42 
were stained for mDia3 (in red), c-Myc (in green) and with Hoechst.  
Bar represents 10µm. 
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7.3 mDia3 depletion induces chromosome misalignment  
The results I presented in the first section of this chapter suggest that mDia3 
acts downstream of DLC2. To better characterize its role, I performed mDia3 
siRNA tranfection in HCE cells.  
Firstly, I tested by WB the efficiency of the depletion (Figure 7.5). 4 siRNAs 
were used to deplete mDia3. All of them, but oligo4, were able to reduce mDia3 
expression efficiently. Despite of the low efficiency of mDia3 oligo4, I chose to use 
a pool of all four to confirm the known role of mDia3 in metaphase.  
Depletion of mDia3 in HCE cells resulted in chromosome misalignment as 
had done DLC2 and Kif1B depletion (Figure 7.6). Quantification of misaligned 
metaphase cells demonstrated that mDia3 depletion significantly increased 
chromosome misalignment and this could be rescued by double depletion DLC2 
and mDia3 (Figure 7.7). 
 
 
 
Figure 7.5 WB for validation of DLC2 KD in HCE cells 
WB for mDia3 expression in HCE cells: C control, P pool of four siRNAs, 1 siRNA 1, siRNA 2, 3 
siRNA 3, 4 siRNA 4. α-tubulin was used as an internal control. 
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Figure 7.6 Cdc42 KD and mDia3 KD cells mitotic spindles are less dense in fibres 
Confocal pictures of control, Cdc42 and mDia3 KD cells stained for DNA and MTs.  
Bar represents 5µm. 
 
Figure 7.7 mDia3 KD results in increased chromosome misalignment  
HCE cells were transfected with Control and mDia3 siRNAs. 
Aligned and misaligned metaphase plates were counted and plotted. Over sixty cells were counted 
per conditions. This experiment was performed three times. Bars represent mean of values.  
** p<0.01 
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7.4  mDia3 and Cdc42 depleted cells are delayed in metaphase  
Due to the similarities to DLC2 KD cells, I was curious to follow up mitosis 
in Cdc42 and mDia3 KD cells and check the timing was affected.  
By performing live imaging with HeLa cells stably transfected for mCherry-
H2B (DNA marker) and α-tubulin-GFP to visualize the mitotic spindle structure, I 
could observe that similarly to DLC2 and Kif1B KD cells, mDia3 and Cdc42 KD 
mitotic spindles spun and rocked within the cell (Figure 7.8 A) (Watch Videos 
Chapter6-Control-atub-h2b, Video Chapter6-Cdc42kd-atub-h2b, Video Chapter6-
mDia3kd-atub-h2b). The metaphase plate was not stable and showed 
chromosomes misaligned from the main axis of the metaphase plate. Depletion of 
Cdc42 and mDia3 caused significantly increased metaphase length (Figure 7.8 B).  
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Figure 7.8 Live imaging of DLC2 and Kif1B KD HeLa cells 
(A) HeLa cells stabely transfected with H2B-mCherry and α-tubulin-GFP and transfected with 
control, Cdc42 or mDia3 siRNAs were filmed throughout mitosis. Pictures were taken with a 
spinning Disc confocal every 2 minutes. White arrows are pointing at misaligned chromosomes. 
Watch Videos Chapter6-Control-atub-h2b, Video Chapter6-Cdc42kd-atub-h2b, Video Chapter6-
mDia3kd-atub-h2b. 
(B) Length of prometaphase and metaphase was calculated and plotted in a graph. . Over 30 cells 
per condition were counted. In charts where data are represented as box-whisker plots, the box 
size represents 75% of the population and the line inside the box represents the median of the 
sample. Maximum (in the upper quartile) and the minimum (in the lower quartile) values are 
represented by the size of the bars (whiskers). 
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7.5 DISCUSSION  
My results indicate that mDia3 functions as an effector of Cdc42 
downstream of DLC2. The fact that DLC2 and Kif1B depletion resulted in 
increased mDia3 protein expression and recruitment to the cell cortex and 
kinetochores indicates that mDia3 is involved in the DLC2 pathway. 
mDia3 depletion caused chromosome misalignment and delays in 
metaphase. Similar results have been described in previous sections for Cdc42 KD. 
Thus, it must also be noticed that Ccd42 and mDia3 depleted cells result in 
misoriented spindles as well. This was in fact already reported for Cdc4278,160, 
suggesting that depletion of Cdc42 impairs more mechanisms than the one of 
spindle positioning regulated by DLC2/Kif1B complex. Also mDia3 seems to be 
involved in more processes since its depletion causes chromosome misalignment, 
spindle positioning defect and misorientation too. This is an indication that mDia3 
is involved in more pathways and most likely acts downstream other signal 
cascades, different from the one linked to DLC2. All together these data support 
the idea that controlled Cdc42 signalling within mitotic cells is important for 
correct chromosome segregation. In fact, both overactivation or deactivation of 
Cdc42 led to the same phenotype.  
Strikingly, mDia3 was not detectable at the cell cortex or at the kinetochores 
in any conditions in which Kif1B was. Hence, mDia3 and Kif1B might compete for 
the same site. In this model, Kif1B would be the protein with highest affinity in 
normal cells. Activation of Cdc42 recruits mDia3 to the MT anchorage points 
(kinetochores and cell cortex) and here it triggers Kif1B mislocalization if Cdc42 is 
overactivated (see final discussion for more details).  
I still have not discussed why chromosome attachment is affected by 
defective Cdc42 signalling. This will be the topic of the next chapter.     
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CHAPTER 8: ANALYSIS OF MICROTUBULE 
DYNAMICS 
8.1 Introduction to the dynamics of the mitotic spindle 
The mitotic spindle is not a steady structure, but a dynamic one and under 
constant change. Its dynamics is due to the forces exerted on the spindle itself 
(Chapter 6) and the polymerization rate of MTs. Another important factor are also 
the forces originating outside the mitotic spindle, coming form the cell cortex (via 
cortical actin), and are transmitted via astral MTs.  
I will present first the role of MT polymerization and, secondly, the 
impacting that cortical actin can have on the spindle stability. 
 
8.1.1 Regulating MT polymerization/depolymerization  
MTs undergo dynamic instability with constant transitioning between 
growing and shrinking states177. It has been shown that this mechanism depends 
on a cap at the tip of the fibre. Loss of this cap is thought to trigger the transition 
from growth to shrinkage, called catastrophe178. The transition depends on tubulin 
concentration, the time between tubulin dilution and catastrophe, and the 
induction of microtubule catastrophes by walking depolymerases. Also, the 
mechanism depends on binding of MT tips to specific anchoring proteins (as those 
at the kinetochores or at the cell cortex) that stabilize tips of growing microtubules. 
There are three categories of MTs in the spindle: kinetochore MTs, 
nonkinetochore fibres and astral MTs. Kinetochore microtubules (K-MTs) have 
plus-ends anchored to the kinetochores and the minus-ends at the spindle poles. 
They pull on chromosomes at kinetochores and silence the spindle assembly 
checkpoint signal that is generated by unattached kinetochores. In mammalian 
cells, about 10–30 K-MTs bind each chromosome. At the same time, K-MTs bundle 
with each other and with nonkinetochore fibres. Since both ends are capped, K-
MT turnover is much slower than the other microtubule classes, with a half-life of 
∼7 min in metaphase spindles and polymerization and depolymerization balanced 
at steady-state (data collected from analyses done in rat Kangaroo kidney 
epithelial cells, Ptk1)152.  
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Nonkinetochore microtubules (nK-MTs) are represented by all 
microtubules that lie between spindle poles other than K-MTs (they are also 
known as interpolar microtubules). The nK-MTs comprise the majority of 
microtubules in mammalian spindles that have been studied by electron 
microscopy. They bundle in groups of 2–6, with anti-parallel interactions 
apparently preferred, during metaphase. Their function is poorly understood, but 
they are thought to help keeping the poles apart, support choromsome 
segregation during anaphase, and ensure its bipolarity. nK-MTs turnover is rapid, 
due to dynamic instability of plus-ends (sliding velocities measured in Xenopus 
extract has an average velocity of ∼2 μm/min)152. 
Astral microtubules (a-MTs) are attached via minus-ends to the centrosome 
and they extend to the cell cortex. They position the spindle within the cell. a-MT 
turnover is comparable to nK-MTs, with growth and shrinkage rates of ∼10–15 
μm/min (data shown in pig kidney epithelial cell, LL-PK1)152. 
 
8.1.2 Actin polarity coordinates spindle dynamics 
External forces are exerted not only inside the spindle but numerous forces 
generated outside of the cell and reflected on the cell cortex and subcortical actin 
influence the life of the mitotic spindle151.  
For example, it was shown that asymmetric meiotic divisions in 
mammalian oocytes depend on the acentric positioning of the spindle to format 
small polar bodies; this is ensured by cortical actin polarization, regulated by 
Cdc42 concentrated in restricted cortical regions, and the consequent recruitment 
of N-WASP, which regulates F-actin remodelling and accumulation179. 
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8.2 Cortical actin is altered upon DLC2 and Kif1B depletion  
Considering that DLC2 is a GAP for Cdc42 and Cdc42 has been reported as 
major player in controlling cortical actin behaviour, I wondered if the phenotype I 
observed in DLC2 depleted cells was due to an aberrant behaviour of cortical 
actin. If this was true, the spindle inside would read the wrong motion and, as a 
consequence, been altered in dynamics of MTs and chromosome attachment 
stability. To investigate this hypothesis, I took advantage of a recently developed 
tool: a fibronectin-coated micropatterned dish, where fibronectin was coated with 
a specific geometry (parallel lines)180. Although artificial, micropatterned 
substrates allow recreation of physiological conditions for controlled in vitro cell 
culture. It is possible to manipulate micropattern shapes and cells will adapt their 
cytoskeletal architecture according to the geometry of their microenvironment. 
This tool is used to study remodelling of actin and microtubule networks in the 
adaptation of cell polarity with respect to external constraints.  
When plated on micropatterned dishes with parallel lines of fibronectin, 
Contol HeLa cells sit on the lines and spread along them. When they enter mitosis, 
retraction fibres form while the cells round up and the mitotic spindle senses their 
direction, and aligns along this line too. Subcortical actin polarizes along the 
direction of the retraction fibres. Retraction fibres exerted strong forces on the 
mitotic cell body, driving spindle positioning151. Moreover the geometry 
introduced with the pattern bias the behaviour of the subcortical actin network: 
the polarization in fact results from a side to side of the fibronectin line. Two 
additional types of actin behaviours can be seen: a non-polarized movement, with 
actin rotating along the cortex or an absence of polarization (Figure 8.1) (Watch 
videos Chapter8-absent polarization, Chapter8-polarized, Chapter8-circular actin).  
DLC2 and Kif1B KD cells showed a significant increase in aberrant actin 
behaviour. The spindle was stable in its position and did not spin, and did not 
follow the actin behaviour anymore (Figure 8.2). Moreover, I looked at the 
positioning of the mitotic spindle compared to the retraction fibres. I did not 
measure the percentages of aberrant angles, but I annotated if the line crossing to 
through the spindle poles was parallel or not to the fibronecting line. Interestingly, 
I detected that the spindle aligned in an indepenent manner from the direction 
dictated by the fibronectin line in depleted cells (Figure 8.2). This data indicates 
that the actin behaviour was not read by the mitotic spindle in depleted cells. This 
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also suggested that astral MTs attaching to the cortex had become insensitive to 
changes in cortical actin.  
I have shown in Chapter 3 that APC and p120catenin were impaired upon 
DLC2 depletion. This already indicated that astral MTs lost their anchoring point. 
The new set of data point toward the same conclusion and suggest that MTs were 
no longer anchored at the cell cortex. 
 
 
 
Figure 8.1 Categories of subcortical actin behaviour  
HeLa cells stably transfected lifeact-EB3GFP were plated on micro-patterned dishes and filmed 
every 1’ from metaphase to follow actin behaviour in mitosis. Two major subgroups of behaviour 
were identified: polarized actin and non-polarized. Non polarized actin groups random 
polarization and absent polarization.  
(A) Sequence of pictures for an example of polarized actin behaviour. To better show the actin 
movement from side to side two kymographs were drawn: one through the plane of the 
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polarization, and on perpendicular. The parallel one shows the alternate left-right shifting; the 
perperdicular one confirm that actin is excluded from this area.  
(B) Sequence of pictures for an example of random polarized actin behaviour. The two 
kymographs show here that actin polarization is everywhere.  
(C) Sequence of pictures for an example of absent polarization. The two kymographs drawn show 
that there is no polarization throughout the cell cortex.  
Watch videos Chapter8-absent polarization, Chapter8-polarized, Chapter8-circular actin. Scale bars 
10µm. 
 
 
 
 
Figure 8.2 DLC2 and Kif1B depletion result in an increase in non-polarized actin behaviour and 
more misaligned mitotic spindles compared to the patterned lines.   
HeLa cells stably transfected lifeact-EB3GFP were plated on micro-patterned dishes and filmed 
every 1’ from metaphase to follow actin behaviour and spindle alignment in mitosis.  
The chart shows percentages of cells with a specific actin behaviour on micropattern dish with 
parallel fibronectin lines (Pol:polarized action; Circ: circular movement; Abs: absent polarization). 
Blue bars represent cells with mitotic spindle aligned with the fibronectin line; red bars, misaligned 
spindle. Over 20 cells per condition were counted. Asterisks indicate significance of the particular 
sub group calculated in comparison with the corrispective control category (shown are means ± 1 
SD; * p<0.05). Scale bars, 10 µm. 
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8.3 DLC2 and Kif1B KD cells have hyperstable MTs 
Since my hypothesis was that there was a defect in MTs, I wondered if their 
dynamics was in fact affected upon depletion of DLC2 and Kif1B KD. I firstly 
thought perhaps fibres in DLC2 and Kif1B KD condition could have been 
unstable, which would have explained the chromosome instability as well as the 
loss of cortical anchorage. Therefore, I treated cells with Taxol to rescue a possible 
instability defect (taxol stabilizes MTs) and looked at the number of misaligned 
metaphase plates. However, Taxol treatment did not rescue the chromosome 
misalignment defect (Figure 8.3); it rather made control cells look worse. This 
suggested that hyperstabilization as well as destabilition can affect chromosome 
misalignment. If DLC2 and Kif1B KD cells were not rescued by taxol stabilization, 
it could be that the fibres were already too stable and therefore insensitive to 
further stabilization.    
 
 
 
 
 
Figure 8.3 Taxol does not rescue DLC2 and Kif1B KD phenotype 
Control, DLC2 KD and Kif1B KD HCE were treated with taxol to test the hypothesis if by 
stabilyzing microtubules, untreated and taxol treated cells. Over 60 cells with aligned or 
misaligned chromosomes were counted for each condition. 
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The hyperstability was also supported by the fact that astral MTs and 
spindle within the spindle (most likely interpolar fibres since they can expand also 
further than the methaphase plate itself and not kinetochore fibres since they are 
constrained by the fixed distance chromosome pole) were longer in DLC2 and 
Kif1B KD cells compared with control cells (Figure 8.4).  
It was shown already that MT growth control cell shape and polarity181. 
Interestingly, it was also shown in Arabidopsis Thaliana that the MT stabilization 
can promote cell elongation on specific axes182,183. Since DLC2 and Kif1B depleted 
cell show hyperstable MTs, I wondered if also the cell shape could have been 
affected. Indeed, since astral MTs had more space to grow than the constrained 
KT-MT and non KT-MT, I have observed in DLC2 and Kif1B depleted cells an 
expansion of the longitudinal axis of the entire spindle (Figure 8.5). On the 
contrary the distance pole-to-pole and the vertical axis did no vary significantly 
from control. 
To test whether the hyperstability defect was also detected inside the 
mitotic spindle, I performed a classic cold treatment assay. This technique tests the 
capability of MTs to depolymerize upon cold treatment. Since KT-MTs are more 
stable than the other MTs, they resist longer to cold, but after about 30’ in control 
situation they become short too. Strikingly, cells depleted of DLC2 and Kif1B 
resisted the cold longer than control cells, and after 30’ they still retained longer 
fibers (Figure 8.6).  This phenotype does also correlates with the abnormalities in 
the metaphase plate compactness. In fact, the categories of cells that retain long 
MTs are classified for type of misalignment: category3 is mild chromosome 
scattering and category2 is excessive chromosome scattering. These two categories 
increased in comparison with cell that still have a normally aligned metaphase 
plate and that is sensitive to cold depolymerization, similarly to the control.   
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Figure 8.4 Astral and KTs fibers are longer in DLC2 and Kif1B KD cells 
(A) Confocal pictures for control, DLC2 and Kif1B KD cells stained for Hoechst, EB1 (red) and α-
Tubulin (green). Bar represents 10µm.  
(B) Quantification of the KT MT length of Control, DLC2 and Kif1B KD HCE cell. Over 50 MTs per 
experiments were counted. 
(C) Quantification of the astral MTs length of Control, DLC2 KD and Kif1B KD HCE cells. Over 50 
MTs per experiments were counted 
 
 
 146 
 
 
Figure 8.5 Mitotic DLC2 and Kif1B cells have a longer horizontal axis. 
(A) Scatter plot of the pole-to-pole distance of Control, DLC2 and Kif1B KD HCE cells. Over 50 
cells per experiments were counted. 
(B) Scatter plot of the horizontal axis length (line from junction to junction passing through both 
spindle poles) of Control, DLC2 and Kif1B KD HCE cells. Over 50 cells per experiments were 
counted. 
(C) Scatter plots of the vertical axis length of Control, DLC2 and Kif1B KD HCE cell. Over 50 cells 
per experiments were counted. 
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Figure 8.6 DLC2 and Kif1B KD cells have MTs with increased resistance to cold. 
(A) Categories of cells counted in the chart in C. Bar represents 10µm. 
(B) Examples of cells of Control, DLC2 and Kif1B KD cells treated with cold. 
(C) Chart of percentages of the 4 categories through time for Control, DLC2 and Kif1B KD HCE 
cells. * p<0.05 ** p<0.01 *** p<0.001. Over 60 cells were counted per condition. This is an exemplar 
experiment, but the results were confirmed three times.   
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8.4 Cdc42 and mDia3 KD induce MTs instability 
Taken into account that DLC2 and Kif1B depleted cells showed MT 
hyperstability and have increased levels of active Cdc42, I wondered if the two 
events were connected. To test this hypothesis, I decided to look at MT dynamics 
in cells depleted of Cdc42 and mDia3. Figure 8.7 shows the results of this assay: in 
contrast to the phenotype observed for DLC2 and Kif1B depletion, mDia3 and 
Cdc42 KD showed higher percentages of short fibres cells at early time-points. 
These data indicate that Cdc42 and mDia3 depletion induced instability of 
kinetochore microtubules. This phenotype does also correlates with the 
abnormalities in the metaphase plate compactness. In fact, the categories of cells 
that have shorter MTs are classified for type of misalignment: category3 is mild 
chromosome scattering and category2 is excessive chromosome scattering. These 
two categories increased in comparison with cell that still have a normally aligned 
metaphase plate and that is sensitive to cold depolymerization, similarly to the 
control. 
To further analyse MT behaviour, I adopted the strategy of live imaging to 
follow EB3 behaviour. I used HeLa cells stably transfected with EB3-GFP and I 
imaged Control, mDia3 KD, Cdc42 KD, DLC2 KD and Kif1B KD cells every 10’. 
From the collected videos, speed, total time and total distance of EB3 comets were 
measured. Whereas speed was not affected in any condition, both total distance 
and total time were altered in all the KD conditions (Figure 8.8) (Watch videos 
Chapter8-Control-EB3, Chapter8-DLC2kd-EB3 Chapter8-Cdc42kd-EB3). For DLC2 
KD and Kif1B KD cells, these parameters were higher than in controls; in Cdc42 
KD and mDia3 KD situation they were lower (Figure 8.9 A and B) (Watch videos 
Chapter8-Control-EB3, Chapter8-DLC2kd-EB3 Chapter8-Cdc42kd-EB3).  
As a last test for regulation of MT stability by DLC2 pathway, I used 
monastrol to measure MT length in monopolar spindles. In this condition, it 
becomes easier to measure MT length as MTs are not overlapping.  Figure 8.10 
and 8.11 show that both astral and Kinetochore microtubules were impaired in 
length. I have chosen HURP as a marker of kinetochore fibres, since it was 
reported to specifically localized along them and excluded from the interpolar 
fibres184; for astral MTs I have chosen PRC-1which was shown to stain interpolar 
fibres in mitosis and fibres in the midbody (which is consider rich in astral MT)185. 
DLC2 and Kif1B depletion caused hyperstability and resulted in longer fibres; 
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Cdc42 and mDia3 KD cells had unstable MTs that were significantly shorter than 
in controls.  
 
 
 
Figure 8.7 MTs in Cdc42 and mDia3 depleted cells depolymerize faster when exposed to cold. 
(A) Categories of cells counted in the chart in C. Bar represents 10µm. 
(B) Example panels of the response of Control, Cdc42 and mDia3 KD cells to cold. 
(C) Chart of percentages of the 4 categories through time for Control, Cdc42 and mDia3 KD HCE 
cells. * p<0.05 ** p<0.01 *** p<0.001 Shown are mean of values of three experiments. Error bars 
represents standard deviations. Over 60 cells per condition were counted. 
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Figure 8.8 DLC2, Kif1B, Cdc42 and mDia3 depletion do not alter MT plus-end speed.   
HeLa cells stably transfected with GFP-EB1 were filmed every 10’’.  From over 10 cells and 10 
followed plus-ends per cell, speed of plus-ends was extracted and plotted in the chart. As shown, 
neither depletion of Cdc42 and mDia3 or DLC2 and Kif1B affected the overall speed of plus-end 
tips. 
In charts where data are represented as box-whisker plots, the box size represents 75% of the 
population and the line inside the box represents the median of the sample. Maximum of the 75% 
(in the upper quartile) and the minimum of the 75% (in the lower quartile) values are represented 
by the size of the bars (whiskers). Over 100 plus ends were analyzed per condition. Watch videos 
Chapter8-Control-EB3, Chapter8-DLC2kd-EB3 Chapter8-Cdc42kd-EB3.  
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Figure 8.9 DLC2, Kif1B, Cdc42 and mDia3 depletion alter the track time and the distance MT 
plus-ends travel.    
HeLa cells stably transfected with GFP-EB1 were filmed every 10’’.  From over 10 cells and 10 
followed plus end per cell, total distance and total track time of plus-ends were extracted and 
plotted in the chart. As shown, Cdc42 and mDia3 depletion results in unstable plus-ends which 
underwent catastrophes after a shorter time compared with controls. On the contrary, DLC2 and 
Kif1B depletion result in longer growing plus end tips, able to travel for longer distances and 
times. 
(A) Total distance chart 
(B) Total track time    
In charts where data are represented as box-whisker plots, the box size represents 75% of the 
population and the line inside the box represents the median of the sample. Maximum of the 75% 
(in the upper quartile) and the minimum of the 75% (in the lower quartile) values are represented 
by the size of the bars (whiskers). Over 100 plus ends were analyzed per condition.  
Watch videos Chapter8-Control-EB3, Chapter8-DLC2kd-EB3 Chapter8-Cdc42kd-EB3. 
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Figure 8.10 Astral MT length quantification 
(A) Confocal pictures for monastrol treated control, DLC2, Kif1B, Cdc42, and mDia3 KD and 
Cdc42/DLC2 KD cells stained for Hoechst and PRC-1 (red). Bar represents 10µm 
(B) Average chart for monastrol treated control, DLC2 KD and Kif1B KD, Cdc42 KD, mDia3 KD 
and Cdc42/DLC2 KD cells, showing the length of astral MTs. 
* p<0.05 ** p<0.01 *** p<0.001 Shown are means and error bars represents standard deviations. 
Over 60 cells were counted per condition. 
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Figure 8.11 Kinetochore MTs length quantification 
(A) Confocal pictures for monastrol treated control, DLC2, Kif1B, Cdc42, mDia3 and Cdc42/DLC2 
KD cells stained for Hoechst and HURP (red). Bar represents 10µm 
(B) Average chart for monastrol treated control, DLC2 KD and Kif1B KD, Cdc42 KD, mDia3 KD 
and Cdc42/DLC2 KD cells, showing the length of kinetochore MTs.  
 * p<0.05 ** p<0.01 *** p<0.001 Shown are means and error bars represents standard deviations. 
Over 60 cells were counted per condition. 
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8.5 DISCUSSION 
I have shown in this chapter that unbalanced levels of active Cdc42 impairs 
MTs dynamics, resulting in the case of higher levels of active Cdc42 in 
hyperstability of MTs, and, in case of less active Cdc42, in MTs instability. It has 
been shown that growing/shrinking ratio is essential to ensure the proper 
kinetochore capture and alignment maintenance186–188. It seems that DLC2 pathway 
does not control the initial chromosome capture, but is essential for chromosome 
attachment maintenance in metaphase.   
Depletion of DCL2 causes an increase in active Cdc42 and results in longer 
MTs. MT instability is intuitively connected to chromosome unattachment, as it is 
likely that short MTs cannot reach a kinetochore or stabilise a chromosome at the 
metaphase plate, also overgrowth triggers the same defect. However, MTs 
overgrowing also fail to attach and stabilse the metaphaseplate. This led to the 
formulation of a hypothesis that dictates a balance in MTs dynamics necessary for 
chromosome segregation efficiency189.  This idea is discussed in details in Chapter 
10, final discussion. 
Considering that MT dynamics and chromosome capture is fundamental to 
ensure a correct chromosome distribution between the two daughter cells, I will 
discuss next the possibility that DLC2 depletion leads to aneuploidy. This idea 
was tested and will be presented in Chapter 9.  
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CHAPTER 9: DLC2 AND KIF1B DEPLETION 
INDUCES ANEUPLOIDY 
9.1 Testing the aneuploidy hypothesis 
Since its discovery and until today, DLC2 is known to act as a tumour 
suppressor, but no one has shown the molecular mechanism that explains why 
lack of DLC2 triggers tumour formation104,136,190. As I speculated in previous 
chapters (Chapter 6, discussion), one possibility could be onset of aneuploidy. 
Considering that DLC2 KD resulted in chromosome misattachment in metaphase 
because of MT overgrowth and taking into account that these cells are delayed in 
metaphase for almost the double of the time control cells take to progress to 
anaphase, induction of aneuploidy is possible and would explain how DLC2 
might function as a tumour suppressor. 
As DLC2 depleted cells spent more time in metaphase and failed in having 
all the chromosomes attached, these cells might finally escape from metaphase in a 
desperate attempt of surviving, without minding if chromosomes will be not 
parted equally.  
To test this hypothesis, I performed an experiment to check aneuploidy in 
DLC2 and Kif1B KD cells versus control HCE cells. Taking advantage of the 
chromosome spread technique, I counted the number of chromosomes in mitotic 
cells and quantified them. As Figure 9.1 shows, the majority of DLC2 and Kif1B 
depletion cells contained less chromosomes than control cells, indicating that 
aneuploidy occurred upon depletion of DLC2 and Kif1B. Interestingly, not many 
cells with higher content of chromosomes were counted, suggesting that these 
cells most likely do not survive, or they loose chromosomes subsequently.  
It is notorious that lack of DNA information is the cause of several 
neurological diseases, cardiac dysfunction, aging and cancer formation191,192–194.  
Here, I presented DLC2 as a major player in maintaining even chromosome 
number in cell division, which might underlie its pathological importance. 
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Figure 9.1 DLC2 and Kif1B depletion causes aneuploidy  
Control and DLC2 or Kif1B KD HCE cells were analysed for chromosome numbers.  
At the top are representative pictures of Control, DLC2 KD and Kif1B KD cells. The chart below 
represents percentage of cells with the indicated chromosome numbers.  
Bars represent means +/- 1SD. * p<0.05 ** p<0.01. Over 20 cells per condition were counted. 
Experiment was repeated 3 times. 
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CHAPTER 10: FINAL DISCUSSION 
10.1 Summary of data presented 
 In this thesis, I show data that shed light on the action of DLC2 as a 
tumour suppressor and its physiological role in epithelial cells. In the first three 
chapters of the results, I demonstrate that DLC2 is a Cdc42GAP involved in cell-
cell junction and spindle stability and describe specific interactors of DLC2; in 
chapter 6, I describe in detail how DLC2 controls the length of mitosis and I 
introduced the concept that junction stability is a paramount factor for the 
satisfaction of the checkpoint in mitosis. Chapters 7 and 8 focus on Cdc42 and 
mDia3 as part of the DLC2 pathway in metapahse and how their regulation is 
important for correct cell division. Chapter 9 contains data that support the 
conclusion that the molecular mechanisms identified is potentially the one that 
underlying the tumour suppressor role of DLC2.    
 
10.2 Epithelial integrity depends on both junction and spindle 
stability 
In an epithelial sheet, mitosis and cell junction remodelling are two 
processes that must be orchestrated in parallel. In a simple epithelium, the main 
aim is to keep proliferating cells in the single layer.  This can be achieved by the 
correct maintenance of cell-cell junctions that anchor the dividing cells to their 
neighbours; at the same time, junctions act as a platform that anchor astral 
microtubules, and stabilize orientation and positioning of the mitotic spindle. 
Only with the right balance of forces acting on the spindle can it split 
chromosomes equally into two daughters cells.  
In animal cells, spindle position is fundamental because it determines the 
location of contractile ring assembly195. In fact, placing the spindle in the center of 
the cell will result in equal-size daughter cells, whereas positioning the spindle 
asymmetrically results in daughter cells of different sizes196. As an example, 
oocytes asymmetrically position the meiotic spindle to preserve most of the 
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cytoplasm in the egg in order to ensure all the specialized mRNA to be retained 
and support the initial stages of development.  
The spindle positioning is controlled by astral microtubules by generating 
pulling forces at the cortex or pulling forces against the cytoplasm. Moreover, 
their attachment to the centrosomes is essential for the generation of pulling forces 
on the astral microtubules to move the spindle. During the years, some key 
molecules had been found controlling spindle positioning at the cell cortex: the 
most known one is dynein197. Dynein has been shown to captures astral MTs and 
pull them along the cell cortex. Later one it was discovered the NuMa-LGN-Giα 
complex that regulates dynein-dynactin pulling of the chromosomes in a 
polarized manner specifically in metaphase and in anaphase198. Another 
interesting player is F-actin. F-actin is required for cortical rigidity to prevent end-
on microtubule contacts from pulling membrane tubules inward instead of 
moving the spindle pole outward82,199. 
Depletion of DLC2 affects both sides: junction stability and cortical actin 
behaviour on one hand, and spindle stability on the other. When I did the live 
imaging experiments, I could observe that more precisely DLC2 depletion affects 
the positioning of the mitotic spindle within the cell, which as a consequence, 
keeps spinning and rocking in the same planar plane. This is due to an aberrant 
behaviour of MT dynamics and their aberrant interaction with the cell cortex. As a 
result of this, actin polarity is perturbed and junctions are ripped off, destabilizing 
even more the whole system.  
In accord with this observation, I have shown that DLC2 localizes along the 
MTs fibres (both astral and kinetochores MTs) and that it interacts with Kif1B and 
cell-cell junction components on the cortical side. In normal cells, Cdc42 can then 
be switched off by DLC2 and mitosis proceeds. The process is not stable, but 
highly dynamic and it is based on a fine equilibrium between levels of active and 
inactive Cdc42 (Figure 10.1).  The correct balance of elements assures that MTs are 
attached at cell-cell junctions and at kinetochores, and that microtubules have the 
appropriate length.  
When this mechanism is perturbed by DLC2 depletion, junctions are 
broken and MTs fibres have a different dynamic behaviour that leads to 
hyperstability and detachment from junctions and kinetochores. In this situation, 
Cdc42 is abnormally active (Figure 10.1). I described in the introduction the role of 
Cdc42 in junction stability and spindle orientation and the importance of its 
regulators. Although most papers mentioned discussed the effect of lack of active 
Cdc42 because of inactivation of specific GEFs or of KD of Cdc42 itself, here we 
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show that also the overactivation represents a danger for the cell and leads to 
destabilization of junctions and alters MTs dynamics. This is in agreement with 
previous work from our laboratory that demonstrated that the Cdc42 GAP 
SH3BP1, which forms a stable junction-associated complex, is required to contain 
junctional Cdc42 signalling and, thereby, maintain functional junctions in 
interphase cells (Elbediwy et al. 2012). As I will discuss in paragraph 10.4 in more 
detail, it is thus fundamental that not too high nor too low levels of active Cdc42 
exist within a epithelial cell.   
DLC2 is required for the maintenance of cell-cell junctions during mitosis 
and the stability of the metaphase plate. DLC2's main substrate during mitosis is 
Cdc42, which is supported by the observation that reduced expression of Cdc42 
could rescue the DLC2 phenotype. A Cdc42 GAP that is selectively required 
during mitosis, but not in interphase cells, for junction maintenance had thus far 
not been identified. MgcRacGAP/CYK-4 had been shown to regulate Cdc42 
during mitosis by expressing a dominant negative mutant that led to a 
prometaphase arrest200. However, unlike DLC2, depletion of MgcRacGAP/CYK-4 
did not affect mitotic progression but caused a defect in cytokinesis98. The activity 
of Cdc42 peaks around metaphase and is then downregulated, which is required 
for mitotic progression200. Hence, DLC2 is required when Cdc42 activity starts to 
decline, further supporting its role as a major Cdc42 regulator during mitosis. 
Interestingly, upon depletion of DLC2 Kif1B is mislocalized from the cell 
cortex, indicating that Kif1B plays a role downstream of DLC2. Such a 
downstream position in the pathway is also supported by the fact that upon 
depletion of Kif1B, DLC2 is not mislocalized.  
For reasons that are still obscure, Kif1B helps stabilizing MT attachment 
and dynamics at the cell cortex and at the kinetochores. This is supported by the 
fact that depletion of Kif1B impairs MTs dynamics. How Kif1B does this, I can 
only speculate (10.6.) 
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Figure 10.1 Model for DLC2 function 
In normal cells, DLC2 specifically inactivates Cdc42 and regulates MT attachment at the cell cortex 
and at the kinetochores.  Kif1B is recruited by DLC2 and helps MTs to be anchored at cell-cell 
junctions and at kinetochores. Upon depletion of DLC2, Kif1B is misplaced and MTs are not  
anchored on the junctional side (with broken junctions) and they are not properly attached at the 
kinetochore plate.  
 
 
10.3 Are mDia3 and Kif1B mutually exclusive?  
To complete the DLC2/Cdc42 pathway, I searched for an effector of Cdc42 
that connects the aberrant MT behaviour and Cdc42. As I described in Chapter 7 
of the results, mDia3 had been suggested to sit at the plus ends of MTs and 
stabilize them. Considering the hyperstable fibre phenotype I detected upon 
depletion of DLC2 and taking into account that DCL2 KD results in overactive 
Cdc42, mDia3 seemed the best candidate to fit into the picture.  
Interestingly, mDia3 behaved in the opposite way of Kif1B: It localized to 
the cell cortex and kinetochores when Cdc42 was active. This let me think about 
the possibility that mDia3 and Kif1B could be mutually exclusive (Figure 10.2 
A,B). A strong evidence that supports my idea is the result showing that in DLC2 
KD cells, expression of an inactive form of Cdc42 rescues the cortical localisation 
of Kif1B and mDia3 is no longer recruited (Figure 10.3).  
Since little is known about Kif1B, it is hard to speculate what the reason for 
this mutual exclusive localization is. It might be that they occupy the same site and 
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that this is dependent on Cdc42 activity. For instance, the activation of Cdc42 and 
its binding to mDia3 could lead to an increase of affinity of mDia3 for the site that 
Kif1B occupies. This would explain why Kif1B is mislocalized upon depletion of 
DLC2 and is brought back into place when Cdc42 DN is overexpressed in the cells.  
 
 
 
Figure 10.2 The alternation of mDia3 and Kif1B at sites that interact with the plus ends of MTs 
(control angle) 
When the right balacance of Cdc42 is maintained, Cdc42 alternates between and active state (Cdc42 
ON) and an inactive state (cdc42 OFF). Depending on the GTP-bound form, mDia3 is recruited at 
the cell cortex. In this situation, Kif1b is excluded from the plus ends of the MTs. Kif1B is 
represented by yellow stars.  
(A) Schematic model of the Control situation  
(B) Exemplar picture of Control HCE cell: in metaphase, the mitotic spindle (stained in green) is 
anchored at the cell-cell junctions and align all the chromosomes unto the metaphase plate.
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Figure 10.3 The alternation of mDia3 and Kif1B at the plus ends of MTs (DLC2 KD angle) 
When DLC2 is depleted, mDia3 is recruited to sites that interact with the plus ends of MTs, due to 
the constant activation of Cdc42.  Upon DLC2 depletion, Kif1b is mislocalized. Kif1B is represented 
by yellow stars.  
(A) Schematic model of the DLC2 KD situation  
(B) Example of DLC2 KD HCE cell: upon depletion of DLC2, the mitotic spindle (stained in green) 
is heavily distorted and unorganized, unable to align all the chromosomes unto the metaphase 
plate.    
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10.4 Too much or too less: it is always a matter of balance 
In Chapter 8, I described how DLC2/Kif1B and Cdc42/mDia3 regulate in 
an opposing fashion the dynamics of MTs: depletion of DLC2 and Kif1B induces 
hyperstabylization of MTs, whereas Cdc42 and mDia3 KD leads to MT instability. 
Both situations alter the mitotic spindle so that the check-point for entry into 
anaphase is delayed, to ensure that chromosomes will be segregated correctly 
despite the abnormal MT dynamics,.  
The mitotic spindle structure is not stiff, but dynamic and continuously 
evolving. Microtubules undergo phases of catastrophe and growth, which is at a 
particularly high-rate at the plus ends. Considering that the turnover is stable in 
the spindle (the half-life is ~7 min of k-MT), the growth and shrinkage rates of 
astral microtubules is about 10–15 μm/min152. Moreover a number of forces 
exerted at the membrane on astral microtubules must be taken into account: motor 
proteins such as dynein and some kinesins (kinesin 1 family members) catch astral 
microtubules and pull them at the cell cortex201,202. 
Comparing the mitotic apparatus to a suspension bridge for convenience, it 
is possible to elucidate this intricate mechanism of forces acting on the structure. 
As in a bridge, there is a platform part suspended (spindle and chromosomes), the 
anchoring part (astral MTs) coupled to a pair of pillars (cell-cell junctions and 
centrosome) on each edge (membrane). When forces are act on the bridge through, 
for example, motor proteins pulling or remodelling of junctions, the bridge 
oscillates and buffers this energy, unloading it onto the pillars (membrane and 
centrosomes)148,203. There is a tolerance threshold, a limit under which oscillations 
occur safely and beyond which the structure collapses. DLC2 regulation is 
responsible for junctional maintenance in metaphase through Cdc42 deactivation 
and localizes Kinesin 1B (Kif1B) at the cell cortex (Figure 10.4 A). If DLC2 is 
depleted, Kif1B is delocalized from the membrane, and mDia3 is recruited by 
active Cdc42, hyperstabilizes MTs, and, finally, junctions start to dissociate. All 
these uncontrolled movements at the cortex affect MTs within the spindle as well, 
leading to MT dissociation from kinetochores  (Figure 10.4 B).  
It is striking that the opposite phenotype caused by depletion of mDia3 and 
Cdc42 induces the same kind of delay in metaphase, but in this case the reason is 
instability of MTs (Figure 10.4 B). In a situation of unstable MTs, the astral MTs are 
not able to reach and be anchored properly at the cell cortex. This leads to 
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excessive spindle movements and, once again, defects in passing the mitotic 
check-point. 
In 2012, Bakhoum and Compton proposed a model of MTs dynamics that 
sees both instability and hyperstability as important factors in the control of the 
mitotic timing and the success of cell division. Quoting, “Hypostable kMT 
attachments fails to adequately satisfy the spindle assembly checkpoint leading to mitotic 
delay or arrest. Hyperstable kMT attachments lose efficient error correction with the 
consequence being the persistence of attachment errors in anaphase and an increase in 
chromosome mis-segregation leading to chromosomal instability (CIN)”189,204. The 
importance of having correct MTs dynamics within a cell is also highlighted by the 
number of tumours caused by mutations that affect genes that hyperstabilize MTs, 
such as the overexpressed CenpH, Cyclin E, Hec1/Ndc80 complex, and MCT-1, or 
the mutated, deleted or underexpressed  APC, β-catenin, pRB, and BRCA1205–209.  
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Figure 10.4 Balance is all that matters 
 (A) The proposed mechanism acts both at cell cortex and at the kinetochores. The cartoon shows 
that to keep epithelial integrity it is necessary to balance between negative regulation of Cdc42 and 
its activation and signalling  via mDia3.    
(B) Phenotype features of Cdc42 KD (right side of he picture) and DLC2 KD (left side). 
 168 
10.5    The paradigm of focal adhesion 
Several papers have shown previously that DLC2 as the other DLCs is 
localized at focal adhesions. I have never detected this in HCE or HeLa cells using 
immunofluorescence. It could be that this difference is caused by the difference in 
the system used. Most of my experiments were done with differentiated epithelial 
cells that had not previously been studied for DLC2. Many focal adhesion proteins 
associate with cell-cell junctions in differentiated epithelial cells, which may 
contribute to the difference in localisation.  
Interestingly, in a Hepatocarcinoma cell line (HepG2 cells) it has been 
reported that expression of DLC2 leads to a block in in G1/S phase progression135. 
This evidence supports the idea of DLC2 as a tumour suppressor that acts directly 
on the length of the cell cycle and regulates its progression. Hence, DLC2 might 
regulate different steps along the cell cycle.  
 
10.6 More can be done: open questions and future perspectives 
One key element for a more complete comprehension of the role of DLC2 in 
physiological and abnormal conditions would be to understand how DLC2 is 
regulated. I showed that DLC2 is not regulated on the expression level during 
mitosis. Hence, it might be regulated by a posttranslational modification, such as 
phosphorylation. It has been described previously that Akt phosphorylates 
DLC2210. Phosphorylation of DLC1 by Akt has been shown to be essential for in 
activation of the tumour suppressor activity, since abrogation of the Akt specific-
phospho site on DLC1 dramatically suppressed cell growth and anchorage-
independent growth. Akt has been reported as a regulator of cell cycle. In 
particular, it positively regulates G1/S transition via inactivation of GSK3-β, 
which results in an increase in Cyclin-D1 expression211.  In 2005, Lee et al advanced 
the hypothesis that Akt could also work as a regulator of G2/M. DLC2 
phosphorylation by Akt has not been characterized in a context of mitosis, but it 
would be interesting to know if it is an activating or inactivating one, and to 
determine the effect on cell cycle progression.  
Poorly characterized are also two of the domains within the protein: the 
START domain and the SAM domain. As previously mentioned, it was shown by 
Lee et al that DLC2 isoform γ induces arrest in cell cycle. Isoform γ lacks the N-
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terminus part of the protein containing the SAM domain. I discussed in the 
introduction how the SAM domain is responsible for protein-protein interactions 
and if we connect this to the phenotype derived from the transfection of the 
truncated portion, we can speculate that the SAM domain is essential for the 
correct regulation of DCL2 in mitosis, since its lack causes an arrest in the cell 
cycle. I must point out, however, that the arrest discussed by Lee is in G1/S 
progression and not during mitosis. Nevertheless, taking all the information into 
count, it might be that a specific interaction via the SAM domain is required for 
Dlc2 function in mitosis 
A captivating idea is that the START domain is involved in the regulation 
of DLC2 activity in a new way.  I presented in the introduction the peculiarity of 
the DLC2 START domain: In contrast to other START domains, the one of DLC2 
lacks what would be the third helix of a canonical, five helix motif. This is 
proposed to be important for the binding of bigger molecules in the pocket. In 
particular, it has been proposed that glucocorticoics could bind the DLC2 START 
domain. It is remarkable that the START domain is contained exclusively in the 
DLC proteins and not in any other GAPs identified in the human genome. This 
could suggest a unique modulation of DLC protein activity through the START 
domain. It would be intriguing to test the hypothesis that an external signal, such 
as glucocorticoids, could actually act directly on DLC2 and regulate its activity 
and its effect on the cell cycle.  
Although this study depicted the mechanism of action of DLC2, I still have 
not explained what the exact role of Kif1B is. Kif1B is a poorly investigated 
kinesin, belonging to the family 3. Despite none of the family 3 members having 
been associated with depolymerising activity, there are no reasons to exclude that 
Kif1B has a depolymerising activity212. An alternative possibility would be that 
Kif1B orchestrates indirectly depolymerization. This idea is supported by the 
evidence that depletion of Kif1B results in longer MTs.  
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